詳細検索

詳細検索

お問い合わせ

製品別、手法別、稼働モード別、素材別、エンドユーザー別、地域別の膜クロマトグラフィー市場 ― 2031年までの世界予測

製品別、手法別、稼働モード別、素材別、エンドユーザー別、地域別の膜クロマトグラフィー市場 ― 2031年までの世界予測


Membrane Chromatography Market by Product, Technique, Operation Mode, Material, End User, Region - Global Forecast to 2031

世界の膜クロマトグラフィー市場は、2026年の0.37億米ドルから2031年までに0.63億米ドルへと拡大し、2026年から2031年までの年間平均成長率(CAGR)は11.3%になると推定されています。 バイオ医薬品の生産増加... もっと見る

 

 

出版社
MarketsandMarkets
マーケッツアンドマーケッツ
出版年月
2026年10月30日
電子版価格
US$4,950
シングルユーザーライセンス
ライセンス・価格情報/注文方法はこちら
納期
通常2営業日以内
ページ数
331
図表数
475
言語
英語

英語原文をAIを使って翻訳しています。


 

サマリー

世界の膜クロマトグラフィー市場は、2026年の0.37億米ドルから2031年までに0.63億米ドルへと拡大し、2026年から2031年までの年間平均成長率(CAGR)は11.3%になると推定されています。 バイオ医薬品の生産増加、バイオ医薬品の研究開発(R&D)の拡大、および従来のクロマトグラフィー技術に比べて膜クロマトグラフィーが持つ運用上の利点に牽引され、当市場は予測期間を通じて着実に成長すると見込まれています。 さらに、下流精製プロセスの洗浄バリデーションに対する規制当局の監視の強化、用途の拡大と多様化、およびシングルユース技術の普及も、市場の成長を後押ししています。 さらに、膜クロマトグラフィーの適用範囲がポリッシングからキャプチャーおよびバインド・アンド・エルート用途へと拡大していること、強化型および連続型バイオプロセスとの統合が進んでいること、新興市場におけるバイオ製造能力の増強などが、新たな機会を生み出している。

2025年時点で、膜材料別に見ると、ポリエーテルサルホン(PES)セグメントが最大のシェアを占めた。
膜材料に基づいて、膜クロマトグラフィー市場は、ポリエーテルスルホン(PES)、セルロース、ハイドロゲル、およびその他の膜材料に分類される。 2025年には、ポリエーテルスルホンが、その高い耐薬品性、機械的強度、透過性、および幅広いバイオプロセス条件との適合性を背景に、膜クロマトグラフィー市場で最大のシェアを占めました。 PES膜は、そのプロセス安定性、スケーラビリティ、およびハイスループット用途への適合性から、膜を用いた分離・精製ワークフローで広く使用されています。 さらに、製薬・バイオ医薬品企業、CROおよびCDMO、ならびに学術・研究機関において、シングルユースのダウンストリーム処理や膜を用いた精製技術の採用が拡大していることも、需要を後押ししている。ろ過および精製分野におけるこの材料の定評ある使用実績と、多様なプロセス条件への適合性が相まって、同セグメントの世界的な主導的地位を支え続けている。

2025年、運転モード別に見ると、膜クロマトグラフィー市場において、フロースルー型膜クロマトグラフィーが最大のシェアを占めた。
動作モードに基づき、膜クロマトグラフィー市場は、フロースルー型膜クロマトグラフィーとバインド・エルート型膜クロマトグラフィーに分類される。 2025年には、バイオ医薬品のダウンストリーム工程における高スループットな不純物除去および精製への広範な利用を背景に、フロースルー型膜クロマトグラフィーが最大の市場シェアを占めた。

フロースルー膜クロマトグラフィーは、迅速な処理、高い流速、低い圧力損失、およびシングルユースワークフローとの互換性を備えています。この技術は、標的生体分子を通過させつつ、宿主細胞タンパク質、DNA、ウイルス、エンドトキシン、およびその他のプロセス由来の不純物を除去するために広く利用されています。 製薬・バイオ医薬品企業やCRO、CDMOにおいて、プロセスの集約化、処理時間の短縮、スケーラブルな下流工程精製に適していることから、この分野の主導的な地位は引き続き支えられています。

2026年から2031年にかけて、膜クロマトグラフィー市場において、アジア太平洋地域が最も高い年平均成長率(CAGR)を記録すると予想される。
膜クロマトグラフィー市場は、地域別に北米、欧州、アジア太平洋、ラテンアメリカ、中東、アフリカに分類される。 アジア太平洋地域は、バイオ医薬品の製造拡大、バイオテクノロジーの研究開発の活発化、CDMO活動の増加、およびバイオ医薬品や先進治療薬の生産への投資拡大に牽引され、予測期間中に最も高い年平均成長率(CAGR)で成長すると推定されています。 さらに、中国、インド、日本、韓国、オーストラリアにおいて、シングルユースのダウンストリームプロセス、ハイスループット精製技術、および先進的な膜クロマトグラフィーソリューションの採用が拡大していることも、成長を後押ししている。地域における製造能力の拡大とバイオプロセスインフラの強化により、同地域全体で膜クロマトグラフィーの能力は引き続き向上している。

本レポートのために実施された一次インタビューは、次のように分類できます。
- 回答者別:供給側(80%)および需要側(20%)
- 役職別:マネージャー(45%)、CXOおよびディレクター(30%)、エグゼクティブ(25%)
- 地域別:北米(40%)、欧州(25%)、アジア太平洋(25%)、ラテンアメリカ(5%)、中東・アフリカ(5%)

ダナハー・コーポレーション(米国)、サルトリアスAG(ドイツ)、メルクKGaA(ドイツ)、サーモフィッシャーサイエンティフィック社(米国)、アジレント・テクノロジーズ社(米国)、 ドナルドソン・カンパニー(米国)、GVS S.p.A.(イタリア)、i3 Membrane GmbH(ドイツ)、レストック・コーポレーション(米国)、島津製作所(日本)、 W. L. ゴア・アンド・アソシエイツ社(米国)、マッヘレイ・ナーゲル社(ドイツ)、マイクロソルブ社(米国)、コベッター社(中国)、ポルヴェア・サイエンシズ社(英国)、 Nupore Filtration Systems(インド)、Sterlitech Corporation(米国)、Microlab Scientific Co., Ltd.(中国)、Nantong FilterBio Membrane Co., Ltd.(中国)、Hahnemühle FineArt GmbH(ドイツ)、 Biocomma Limited(中国)、Astrea Bioseparations(英国)、Bio-Rad Laboratories, Inc.(米国)、Membrane Solutions(中国)、およびGL Sciences Inc.(日本)などが、膜クロマトグラフィー製品およびソリューションを提供する主要企業の一部である。

調査対象分野
本調査レポートでは、膜クロマトグラフィー市場を、製品別(カプセル、カセット、カートリッジ、シリンジフィルター、フィルタープレート、スピンカラム、膜ディスクおよびシート、 その他の消耗品・付属品)ごとに分類し、さらに技術別[イオン交換膜クロマトグラフィー(陰イオン交換膜クロマトグラフィーおよび陽イオン交換膜クロマトグラフィー)、アフィニティ膜クロマトグラフィー、疎水性相互作用膜クロマトグラフィー]、操作モード別(フロースルー型膜クロマトグラフィーおよび結合・溶出型膜クロマトグラフィー)、 膜材料(ポリエーテルサルホン、セルロース、ハイドロゲル、およびその他の膜材料)、エンドユーザー(製薬・バイオ医薬品企業、CROおよびCDMO、学術・研究機関)、および地域(北米、欧州、アジア太平洋、ラテンアメリカ、中東、アフリカ)ごとに分類している。

本レポートでは、膜クロマトグラフィー市場における主要な成長要因に加え、課題、機会、および制約要因について取り上げています。 主要な業界プレイヤーに関する包括的な分析を通じて、各社の事業概要、製品・サービスポートフォリオ、および提携、パートナーシップ、事業拡大、契約、買収、最近の動向を含む主要戦略に関する洞察を提供しています。また、本レポートには、膜クロマトグラフィー市場における主要企業および新興スタートアップの競合分析も含まれています。

本レポートを購入する主なメリット
本レポートは、膜クロマトグラフィー市場に関する包括的な概要を提供しています。各セグメントにおける市場規模と今後の成長機会を評価しています。また、主要な市場プレーヤーについて、企業概要、最近の動向、主要な市場戦略などを含む詳細な競合分析も掲載しています。

本レポートでは、以下の点について洞察を提供しています:
- 主な推進要因の分析(従来のクロマトグラフィー技術に比べて膜クロマトグラフィーがもたらす利点、バイオ医薬品の研究開発の拡大、下流精製プロセスの洗浄バリデーションに対する規制当局の監視強化、バイオ医薬品の生産拡大、用途の拡大と多様化、およびシングルユース技術への移行)、 制約要因(大規模製造における膜クロマトグラフィー製品の採用が限定的であること、およびフッ素化物質の使用制限)、 機会(新興市場、連続バイオプロセスとの統合、および膜クロマトグラフィーの用途がポリッシングからキャプチャーおよびバインド・アンド・エルートへと拡大していること)、ならびに課題(クロマトグラフィーに代わる技術の存在および膜クロマトグラフィーに伴う技術的制約)が、膜クロマトグラフィー市場の成長に影響を与えている。
- 製品開発/イノベーション:膜クロマトグラフィー市場における新発売製品に関する詳細な分析。
- 市場開発:収益性の高い市場に関する包括的な情報。本レポートでは、さまざまな地域にわたる市場分析を行っている。
- 市場の多角化:膜クロマトグラフィー市場における新製品、未開拓地域、最近の動向、および投資に関する網羅的な情報。
- 競合分析:Danaher Corporation(米国)、Sartorius AG(ドイツ)、Merck KGaA(ドイツ)、Thermo Fisher Scientific Inc.(米国)、 i3 Membrane GmbH(ドイツ)、Agilent Technologies, Inc.(米国)、Donaldson Company, Inc.(米国)、GVS S.p.A.(イタリア)、Restek Corporation(米国)、株式会社島津製作所(日本)、 W. L. ゴア・アンド・アソシエイツ社(米国)、マッヘレイ・ナーゲル社(ドイツ)、マイクロソルブ社(米国)、コベッター社(中国)、ポルベア・サイエンシズ社(英国)、 Nupore Filtration Systems(インド)、Sterlitech Corporation(米国)、Microlab Scientific Co., Ltd.(中国)、Nantong FilterBio Membrane Co., Ltd.(中国)、 ハーネミュレ・ファインアート社(ドイツ)、バイオコムマ社(中国)、アストレア・バイオセパレーションズ社(英国)、バイオ・ラッド・ラボラトリーズ社(米国)、メンブレン・ソリューションズ社(中国)、およびGLサイエンシズ社(日本)。

また、本レポートは、ステークホルダーが膜クロマトグラフィー市場の動向を理解するのに役立ち、主要な推進要因、制約要因、課題、および機会に関する情報を提供しています。 主要な業界プレイヤーについて詳細な分析を行い、その戦略、製品・サービスの発売、買収、提携、共同事業、最近の動向、投資、資金調達、ブランド・製品の比較、ベンダー評価、および膜クロマトグラフィー分野の財務指標に関する洞察を提供しています。



お問い合わせ

お問合せ種類/内容 *

補足が有ればご記入ください
貴社名*
ご担当者名 * 姓 名
メールアドレス *

ページTOPに戻る


目次

1 はじめに 32
1.1 調査の目的 32
1.2 市場の定義 32
1.3 調査範囲 33
1.3.1 市場セグメンテーションおよび対象地域 33
1.3.2 調査対象および除外項目 34
1.3.3 対象期間 34
1.3.4 対象通貨 35
1.3.5 対象単位 35
1.4 ステークホルダー 35
1.5 変更点の概要 35

2 概要 37
2.1 市場のハイライトと主要な洞察 37
2.2 主要市場参加者:戦略的展開の概況 39
2.3 膜クロマトグラフィー市場における破壊的トレンド 40
2.4 高成長セグメント 41
2.5 地域別概況:市場規模、成長率、および予測 42

3 プレミアム・インサイト 44
3.1 膜クロマトグラフィー市場の概要 44
3.2 北米:膜クロマトグラフィー市場、運用形態および国別 45
3.3 膜クロマトグラフィー市場:地域別の成長機会 46
3.4 膜クロマトグラフィー市場シェア(エンドユーザー別) 46

4 市場の概要 47
4.1 はじめに 47
4.2 市場動向 47
4.2.1 成長要因 48
4.2.1.1 従来のクロマトグラフィー技術に比べ、膜クロマトグラフィーがもたらす利点 48
4.2.1.2 バイオ医薬品の研究開発の拡大 50
4.2.1.3 ダウンストリーム精製プロセスの洗浄バリデーションに対する規制当局の監視の強化 51
4.2.1.4 バイオ医薬品の生産量の増加 51
4.2.1.5 用途の拡大と多様化 52
4.2.1.6 シングルユース技術への移行 53
4.2.2 制約要因 54
4.2.2.1 大規模製造における膜クロマトグラフィー製品の利用が限定的であること 54
4.2.2.2 フッ素化物質の使用制限 55
4.2.3 機会 55
4.2.3.1 新興市場 55
4.2.3.2 連続バイオプロセスとの統合 56
4.2.3.3 膜クロマトグラフィーの用途拡大:精製から捕捉および結合・溶出アプリケーションへ 56
4.2.4 課題 57
4.2.4.1 クロマトグラフィーに代わる技術の存在 57
4.2.4.2 膜クロマトグラフィーに伴う技術的制約 58
4.3 未充足ニーズと未開拓分野 58
4.4 相互に関連する市場とセクター横断的な機会 59
4.5 ティア1/2/3の主要企業による戦略的動き 59

5 業界の動向 60
5.1 ポーターの5つの力分析 60
5.1.1 供給者の交渉力 61
5.1.2 購入者の交渉力 61
5.1.3 新規参入の脅威 61
5.1.4 代替品の脅威 61
5.1.5 競争の激しさ 62
5.2 マクロ経済の見通し 62
5.2.1 はじめに 62
5.2.2 GDPの推移と予測 62
5.2.3 世界の膜クロマトグラフィー産業の動向 63
5.3 バリューチェーン分析 64
5.4 エコシステム分析 65
5.5 価格設定分析 67
5.5.1 主要企業別 膜クロマトグラフィー製品の平均販売価格の推移
68
5.5.2 地域別 平均販売価格の推移 69
5.6 貿易データ 70
5.6.1 輸入動向(HSコード 842129) 70
5.6.2 輸出動向(HSコード 842129) 72
5.7 2026年~2027年の主要な会議・イベント 73
5.8 顧客のビジネスに影響を与えるトレンド/ディスラプション 74
5.9 投資および資金調達の状況 75
5.9.1 ベンチャーキャピタル/プライベート・エクイティ投資の動向およびスタートアップの動向 75
5.10 2025年の米国関税が膜クロマトグラフィー市場に与える影響 76
5.10.1 はじめに 76
5.10.2 主な関税率 76
5.10.3 価格への影響分析 77
5.10.4 国・地域への影響 78
5.10.4.1 米国 78
5.10.4.2 欧州 78
5.10.4.3 アジア太平洋地域 78
5.10.5 最終用途産業への影響 79
5.10.5.1 製薬・バイオテクノロジー企業 79
5.10.5.2 CROおよびCDMO 79
5.10.5.3 学術・研究機関 80

6 技術の進歩、AIがもたらす影響、特許、そしてイノベーション 81
6.1 技術分析 81
6.1.1 主要な新興技術 81
6.1.1.1 シングルユース技術 81
6.1.1.2 連続膜クロマトグラフィー 83
6.1.1.3 ナノファイバー系膜クロマトグラフィー 83
6.1.2 補完的技術 83
6.1.2.1 ハイスループットスクリーニング 83
6.1.2.2 質量分析法 83
6.1.3 関連技術 84
6.1.3.1 モノリスクロマトグラフィー 84
6.1.3.2 タンジェンシャルフローろ過 84
6.2 技術・製品ロードマップ 85
6.3 特許分析 85
6.3.1 膜クロマトグラフィー特許の主要出願者/権利者(企業) 86
6.4 将来の応用 88
6.5 AI/ジェネレーティブAIが膜クロマトグラフィー市場に与える影響 89
6.5.1 膜クロマトグラフィーワークフローにおけるベストプラクティス 90
6.5.2 AI導入の事例研究 91
6.5.3 相互に連携する隣接エコシステムと市場プレイヤーへの影響 91
6.5.4 膜クロマトグラフィー市場における生成AI導入に対する顧客の準備状況 91

7 規制環境と持続可能性への取り組み 93
7.1 地域ごとの規制およびコンプライアンス 93
7.1.1 規制機関、政府機関、およびその他の組織 93
7.1.2 規制の枠組み 96
7.1.2.1 北米 96
7.1.2.2 欧州 97
7.1.2.3 アジア太平洋地域 97
7.1.2.4 ラテンアメリカ 98
7.1.2.5 中東・アフリカ 98
7.1.3 業界基準 98
7.2 サステナビリティの取り組み 99
7.3 規制政策がサステナビリティ・イニシアチブに与える影響 99
7.4 認証、表示、および環境基準 99

8 顧客環境と購買行動 100
8.1 意思決定プロセス 100
8.2 購入者のステークホルダーおよび購入評価基準 100
8.2.1 購入プロセスにおける主要なステークホルダー 100
8.2.2 エンドユーザー別の主要な購入基準 101
8.3 導入の障壁と社内の課題 103
8.4 各種エンドユーザー産業における未充足ニーズ 103
8.5 市場の収益性 103

9 膜クロマトグラフィー市場(製品別) 104
9.1 はじめに 105
9.2 カプセル、カセット、およびカートリッジ 106
9.2.1 高スループット、シングルユース、および
商業規模の精製における採用拡大が市場成長を牽引 106
9.3 シリンジフィルター 109
9.3.1 需要を支える試料調製および分析試験量の増加 109
9.4 フィルタープレート 111
9.4.1 急速な普及を支える高スループットスクリーニングおよびプロセス開発の拡大 111
9.5 スピンカラム 114
9.5.1 複数の小規模サンプルの処理を容易にし、
市場の成長を促進 114
9.6 膜ディスクおよびシート 117
9.6.1 様々なウイルスおよびタンパク質精製用途における分離ツールとしての利用 117
9.7 その他の消耗品および付属品 120

10 膜クロマトグラフィー市場(手法別) 123
10.1 はじめに 124
10.2 イオン交換膜クロマトグラフィー 124
10.2.1 陰イオン交換膜クロマトグラフィー 128
10.2.1.1 モノクローナル抗体の精製における採用拡大が成長を牽引 128
10.2.2 陽イオン交換膜クロマトグラフィー 131
10.2.2.1 市場成長を支えるバイオ医薬品製造向け高度なクロマトグラフィー技術への需要の高まり 131
10.3 アフィニティ膜クロマトグラフィー 134
10.3.1 ポリッシングから高付加価値の捕捉用途への拡大が、市場で最も急速な成長を牽引 134
10.4 疎水性相互作用膜クロマトグラフィー 137
10.4.1 生体分子精製におけるHIMC技術の採用拡大が市場を牽引 137

11 膜クロマトグラフィー市場(稼働モード別) 140
11.1 はじめに 141
11.2 フロースルー膜クロマトグラフィー 141
11.2.1 市場を牽引するバイオ医薬品の開発への注目が高まっている 141
11.3 バインド・エルート型膜クロマトグラフィー 144
11.3.1 バイオ医薬品製造における採用拡大が
市場の成長を後押し 144

12 膜クロマトグラフィー市場(膜材料別) 147
12.1 はじめに 148
12.2 ポリエーテルサルホン 148
12.2.1 高品質な膜材料への需要の高まりが成長を牽引 148
12.3 セルロース 152
12.3.1 強度、軽量性、生分解性――採用を後押しする主要要因 152
12.4 ハイドロゲル 155
12.4.1 市場成長を促進するための膜ファウリング低減ニーズの高まり 155
12.5 その他の膜材料 158

13 膜クロマトグラフィー市場(エンドユーザー別) 162
13.1 はじめに 163
13.2 製薬・バイオ医薬品企業 163
13.2.1 セグメントにおけるリーダーシップを維持するための大規模なバイオ医薬品製造と先進治療パイプラインの拡大 163
13.3 CROSおよびCDMOS 166
13.3.1 市場を牽引する製薬・バイオ医薬品企業による研究開発サービスのアウトソーシング増加 166
13.4 学術・研究機関 169
13.4.1 バイオ医薬品開発に向けた研究開発活動の急増が
市場を牽引 169

14 膜クロマトグラフィー市場(地域別) 173
14.1 はじめに 174
14.2 北米 174
14.2.1 米国 178
14.2.1.1 バイオ医薬品の特許満了が市場の成長を後押し 178
14.2.2 カナダ 181
14.2.2.1 市場を牽引するバイオ製造能力の向上に向けた投資の拡大 181
14.3 ヨーロッパ 184
14.3.1 ドイツ 187
14.3.1.1 市場を牽引するバイオ医薬品製造能力の向上に向けた主要市場プレーヤーによる投資の拡大 187
14.3.2 英国 190
14.3.2.1 市場の成長を支えるバイオテクノロジー産業の急成長 190
14.3.3 フランス 192
14.3.3.1 市場成長を促進するためのバイオ生産能力の向上への注目の高まり 192
14.3.4 イタリア 195
14.3.4.1 市場を牽引するバイオテクノロジー産業の成長と研究開発活動の高まり 195
14.3.5 スペイン 197
14.3.5.1 バイオテクノロジー企業の増加が市場を牽引 197
14.3.6 その他の欧州諸国 199
14.4 アジア太平洋地域 202
14.4.1 中国 205
14.4.1.1 市場を牽引する施設拡張への注目の高まり 205
14.4.2 日本 208
14.4.2.1 市場を牽引する政府主導の取り組みの拡大と施設拡張への注目の高まり 208
14.4.3 インド 210
14.4.3.1 バイオシミラーの承認件数の増加が市場を牽引 210
14.4.4 韓国 213
14.4.4.1 バイオプロセス分野の発展に向けた戦略的提携の拡大が市場成長を支える 213
14.4.5 オーストラリア 215
14.4.5.1 成長を続けるバイオ医薬品製造業界が市場を牽引 215
14.4.6 アジア太平洋その他の地域 217
14.5 ラテンアメリカ 220
14.5.1 ブラジル 223
14.5.1.1 バイオ医薬品への需要増加が市場を牽引 223
14.5.2 メキシコ 225
14.5.2.1 バイオ医薬品生産に対する政府支援の拡大が市場成長を支える 225
14.5.3 その他のラテンアメリカ 227
14.6 中東 230
14.6.1 GCC諸国 232
14.6.1.1 サウジアラビア 235
14.6.1.1.1 市場を牽引する医療分野の進歩への注目の高まり 235
14.6.1.2 アラブ首長国連邦 237
14.6.1.2.1 バイオ医薬品分野の進展が市場成長を後押し 237
14.6.1.3 その他のGCC諸国 240
14.6.2 中東のその他の地域 242
14.7 アフリカ 245
14.7.1 バイオ医薬品の開発・製造に向けた資金調達の増加が市場成長を後押し 245

15 競争環境 248
15.1 概要 248
15.2 主要企業の戦略/競争優位性 248
15.2.1 膜クロマトグラフィー市場における主要企業の戦略の概要 249
15.3 売上高分析(2021年~2025年) 250
15.4 市場シェア分析 251
15.5 企業評価マトリックス:主要企業(2025年) 254
15.5.1 スター企業 254
15.5.2 新興リーダー企業 254
15.5.3 普及型企業 254
15.5.4 参入企業 254
15.5.5 企業の事業展開:主要企業、2025年 256
15.5.5.1 企業の事業展開 256
15.5.5.2 地域別事業展開 256
15.5.5.3 製品別事業展開 257
15.5.5.4 技術のフットプリント 258
15.5.5.5 膜材料のフットプリント 259
15.6 企業評価マトリックス:スタートアップ/中小企業、2025年 260
15.6.1 先進的な企業 260
15.6.2 対応力のある企業 260
15.6.3 ダイナミックな企業 260
15.6.4 スタート地点にある企業 260
15.6.5 競争力ベンチマーク:スタートアップ/中小企業、2025年 262
15.6.5.1 主要なスタートアップ/中小企業の詳細リスト 262
15.6.5.2 スタートアップ/中小企業の競争力ベンチマーク 263
15.7 企業評価と財務指標 264
15.7.1 財務指標 264
15.7.2 企業価値評価 264
15.8 ブランド/製品比較 265
15.9 競争シナリオ 266
15.9.1 製品発売 266
15.9.2 取引 267
15.9.3 事業拡大 268

16 企業概要 269
16.1 はじめに 269
16.2 主要企業 269
16.2.1 ダナハー・コーポレーション 269
16.2.1.1 事業概要 269
16.2.1.2 取り扱い製品 270
16.2.1.3 最近の動向 272
16.2.1.3.1 事業拡大 272
16.2.1.3.2 その他の動向 272
16.2.1.4 MnMの見解 273
16.2.1.4.1 主な強み 273
16.2.1.4.2 戦略的選択 273
16.2.1.4.3 弱点と競合上の脅威 273
16.2.2 SARTORIUS AG 274
16.2.2.1 事業概要 274
16.2.2.2 提供製品 275
16.2.2.3 最近の動向 278
16.2.2.3.1 新製品の発売 278
16.2.2.3.2 取引 278
16.2.2.4 MnMの見解 278
16.2.2.4.1 主な強み 278
16.2.2.4.2 戦略的選択 278
16.2.2.4.3 弱点と競合上の脅威 279
16.2.3 MERCK KGAA 280
16.2.3.1 事業概要 280
16.2.3.2 提供製品 281
16.2.3.3 最近の動向 282
16.2.3.3.1 製品の発売 282
16.2.3.4 MnMの見解 282
16.2.3.4.1 主な強み 282
16.2.3.4.2 戦略的選択 282
16.2.3.4.3 弱点と競合上の脅威 282
16.2.4 サーモフィッシャーサイエンティフィック社 283
16.2.4.1 事業概要 283
16.2.4.2 提供製品 284
16.2.4.3 最近の動向 285
16.2.4.3.1 取引 285
16.2.4.3.2 事業拡大 285
16.2.4.4 MnMの見解 286
16.2.4.4.1 主な強み 286
16.2.4.4.2 戦略的選択 286
16.2.4.4.3 弱点と競合上の脅威 286
16.2.5 アジレント・テクノロジーズ社 287
16.2.5.1 事業概要 287
16.2.5.2 提供製品 289
16.2.5.3 最近の動向 289
16.2.5.3.1 事業拡大 289
16.2.6 ドナルドソン・カンパニー社 290
16.2.6.1 事業概要 290
16.2.6.2 提供製品 291
16.2.6.3 最近の動向 292
16.2.6.3.1 新製品の発売 292
16.2.6.3.2 事業拡大 292
16.2.7 島津製作所 293
16.2.7.1 事業概要 293
16.2.7.2 提供製品 294
16.2.8 GVS S.P.A. 295
16.2.8.1 事業概要 295
16.2.8.2 提供製品 297
16.2.9 I3 MEMBRANE GMBH 298
16.2.9.1 事業概要 298
16.2.9.2 提供製品 298
16.2.9.3 最近の動向 299
16.2.9.3.1 新製品の発売 299
16.2.10 RESTEK CORPORATION 300
16.2.10.1 事業概要 300
16.2.10.2 提供製品 300
16.2.11 W. L. GORE & ASSOCIATES, INC. 301
16.2.11.1 事業概要 301
16.2.11.2 提供製品 301
16.2.11.3 最近の動向 302
16.2.11.3.1 新製品の発売 302
16.2.11.3.2 取引 302
16.2.12 MACHEREY-NAGEL GMBH & CO. KG 303
16.2.12.1 事業概要 303
16.2.12.2 提供製品 303
16.2.12.3 最近の動向 304
16.2.12.3.1 新製品の発売 304
16.2.12.3.2 取引実績 304
16.2.13 MICROSOLV 305
16.2.13.1 事業概要 305
16.2.13.2 提供製品 305
16.3 その他の主要企業 306
16.3.1 COBETTER 306
16.3.2 PORVAIR SCIENCES LTD. 306
16.3.3 NUPORE FILTRATION SYSTEMS 307
16.3.4 スターリテック・コーポレーション 307
16.3.5 マイクロラボ・サイエンティフィック株式会社 308
16.3.6 南通フィルターバイオ・メンブレン株式会社 308
16.3.7 ハーネミュール・ファインアート社 309
16.3.8 バイオコマ社 309
16.3.9 アストレア・バイオセパレーションズ社 310
16.3.10 バイオ・ラッド・ラボラトリーズ社 310
16.3.11 メンブレン・ソリューションズ社 311
16.3.12 GLサイエンシズ社 311

17 研究方法論 312
17.1 調査データ 312
17.1.1 二次データ 313
17.1.1.1 主要な二次資料 313
17.1.1.2 二次調査から得られた主要なデータ 313
17.1.2 一次データ 314
17.1.2.1 主要な一次調査対象者 314
17.1.2.2 一次インタビューの内訳 314
17.1.2.3 一次情報源からの主要データ 314
17.2 市場規模の推計 315
17.2.1 2025年の世界の膜クロマトグラフィー市場の推計 315
17.2.1.1 手法 1:企業売上高分析に基づく推計(ボトムアップ法) 315
17.2.1.2 手法 2:一次調査 317
17.2.1.2.1 主要な業界インサイト 317
17.2.1.3 手法3:MnMリポジトリ分析 317
17.2.2 2025年のセグメント別市場規模推計 318
17.3 市場成長率の予測 319
17.4 データの三角測量 321
17.5 調査の前提条件 322
17.6 調査の限界およびリスク評価 323

18 付録 324
18.1 ディスカッション・ガイド 324
18.2 ナレッジストア:MarketsandMarketsのサブスクリプション・ポータル 327
18.3 カスタマイズオプション 329
18.4 関連レポート 329
18.5 著者情報 330

ページTOPに戻る



図表リスト

FIGURE 1 MEMBRANE CHROMATOGRAPHY MARKET SEGMENTATION 33.
FIGURE 2 MEMBRANE CHROMATOGRAPHY MARKET: YEARS CONSIDERED 34.
FIGURE 3 MARKET SCENARIO 38.
FIGURE 4 GLOBAL MEMBRANE CHROMATOGRAPHY MARKET, 2024–2031 38.
FIGURE 5 MAJOR STRATEGIES ADOPTED BY KEY PLAYERS IN MEMBRANE CHROMATOGRAPHY MARKET, 2023–2026 39.
FIGURE 6 DISRUPTIONS INFLUENCING GROWTH OF MEMBRANE CHROMATOGRAPHY MARKET 40.
FIGURE 7 HIGH-GROWTH SEGMENTS IN MEMBRANE CHROMATOGRAPHY MARKET, 2026–2031 41.
FIGURE 8 ASIA PACIFIC TO REGISTER HIGHEST CAGR IN MEMBRANE CHROMATOGRAPHY MARKET, IN TERMS OF VALUE, DURING FORECAST PERIOD 42.
FIGURE 9 RISING BIOPHARMACEUTICAL PRODUCTION AND GROWING DEMAND FOR FLEXIBLE, HIGH-THROUGHPUT DOWNSTREAM PURIFICATION TO SUPPORT MARKET EXPANSION 44.
FIGURE 10 FLOW-THROUGH MEMBRANE CHROMATOGRAPHY AND US ACCOUNTED FOR LARGEST SHARES OF MEMBRANE CHROMATOGRAPHY MARKET IN NORTH AMERICA IN 2025 45.
FIGURE 11 ASIA PACIFIC LIKELY TO BE FASTEST-GROWING MARKET IN GLOBAL MEMBRANE CHROMATOGRAPHY MARKET DURING FORECAST PERIOD 46.
FIGURE 12 PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES TO DOMINATE MARKET DURING FORECAST PERIOD 46.
FIGURE 13 MEMBRANE CHROMATOGRAPHY MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 47.
FIGURE 14 CLINICAL TRIAL OVERVIEW OF GENE THERAPY PRODUCTS, Q4 2025 53.
FIGURE 15 MEMBRANE CHROMATOGRAPHY MARKET: PORTER’S FIVE FORCES ANALYSIS 60.
FIGURE 16 GLOBAL GDP GROWTH, 2020–2030 63.
FIGURE 17 MEMBRANE CHROMATOGRAPHY MARKET: VALUE CHAIN ANALYSIS 64.
FIGURE 18 MEMBRANE CHROMATOGRAPHY MARKET ECOSYSTEM 66.
FIGURE 19 AVERAGE SELLING PRICE TREND OF MEMBRANE CHROMATOGRAPHY PRODUCTS, 2023–2025 (USD) 69.
FIGURE 20 AVERAGE SELLING PRICE OF MEMBRANE CHROMATOGRAPHY PRODUCTS, BY REGION, 2025 (USD) 70.
FIGURE 21 REVENUE SHIFT AND NEW REVENUE POCKETS FOR PLAYERS IN MEMBRANE CHROMATOGRAPHY MARKET 74.
FIGURE 22 TOP APPLICANTS/OWNERS (COMPANIES) FOR MEMBRANE CHROMATOGRAPHY PATENTS, 2015–2025 86.
FIGURE 23 IMPACT OF AI/GENAI ON MEMBRANE CHROMATOGRAPHY MARKET 90.
FIGURE 24 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF MEMBRANE CHROMATOGRAPHY PRODUCTS 100.
FIGURE 25 KEY BUYING CRITERIA FOR MEMBRANE CHROMATOGRAPHY PRODUCTS, BY END USER 101.
FIGURE 26 NORTH AMERICA: MEMBRANE CHROMATOGRAPHY MARKET SNAPSHOT 175.
FIGURE 27 TOTAL BIOTECHNOLOGY FUNDING BY NATIONAL INSTITUTES OF HEALTH, 2013–2025 179.
FIGURE 28 ASIA PACIFIC: MEMBRANE CHROMATOGRAPHY MARKET SNAPSHOT 202.
FIGURE 29 REVENUE ANALYSIS OF KEY PLAYERS IN MEMBRANE CHROMATOGRAPHY MARKET,.
2021–2025 (USD MILLION) 251.
FIGURE 30 MARKET SHARE ANALYSIS OF KEY PLAYERS IN MEMBRANE CHROMATOGRAPHY MARKET, 2025 252.
FIGURE 31 MEMBRANE CHROMATOGRAPHY MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2025 255.
FIGURE 32 MEMBRANE CHROMATOGRAPHY MARKET: COMPANY FOOTPRINT, 2025 256.
FIGURE 33 MEMBRANE CHROMATOGRAPHY MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2025 261.
FIGURE 34 EV/EBITDA OF KEY VENDORS, 2026 264.
FIGURE 35 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY VENDORS, 2026 264.
FIGURE 36 MEMBRANE CHROMATOGRAPHY MARKET: BRAND/PRODUCT COMPARATIVE ANALYSIS 265.
FIGURE 37 DANAHER CORPORATION: COMPANY SNAPSHOT (2025) 270.
FIGURE 38 SARTORIUS AG: COMPANY SNAPSHOT (2025) 275.
FIGURE 39 MERCK KGAA: COMPANY SNAPSHOT (2025) 281.
FIGURE 40 THERMO FISHER SCIENTIFIC INC.: COMPANY SNAPSHOT (2025) 284.
FIGURE 41 AGILENT TECHNOLOGIES, INC.: COMPANY SNAPSHOT (2025) 288.
FIGURE 42 DONALDSON COMPANY, INC.: COMPANY SNAPSHOT (2025) 291.
FIGURE 43 SHIMADZU CORPORATION: COMPANY SNAPSHOT (2025) 294.
FIGURE 44 GVS S.P.A.: COMPANY SNAPSHOT (2025) 296.
FIGURE 45 MEMBRANE CHROMATOGRAPHY MARKET: RESEARCH DESIGN 312.
FIGURE 46 MEMBRANE CHROMATOGRAPHY MARKET: BREAKDOWN OF PRIMARIES 314.
FIGURE 47 GLOBAL MEMBRANE CHROMATOGRAPHY MARKET ESTIMATION, 2025 315.
FIGURE 48 MEMBRANE CHROMATOGRAPHY MARKET: COMPANY REVENUE ANALYSIS (BOTTOM-UP APPROACH) (2025) 316.
FIGURE 49 ILLUSTRATIVE EXAMPLE OF DANAHER CORPORATION: REVENUE ANALYSIS (2025) 316.
FIGURE 50 MEMBRANE CHROMATOGRAPHY MARKET: INSIGHTS FROM PRIMARIES 317.
FIGURE 51 SEGMENTAL MARKET SIZE ESTIMATION: TOP-DOWN APPROACH 318.
FIGURE 52 MEMBRANE CHROMATOGRAPHY MARKET: CAGR PROJECTIONS 320.
FIGURE 53 MEMBRANE CHROMATOGRAPHY MARKET: DATA TRIANGULATION 321.
TABLE 1 MEMBRANE CHROMATOGRAPHY MARKET: IMPACT ANALYSIS OF MARKET DYNAMICS 48.
TABLE 2 NATIONAL INSTITUTES OF HEALTH FUNDING FOR RESEARCH AREAS RELEVANT TO MEMBRANE CHROMATOGRAPHY, 2020–2025 (USD MILLION) 49.
TABLE 3 FUNDING INVESTMENTS IN MEMBRANE CHROMATOGRAPHY & DOWNSTREAM PURIFICATION, 2023–2026 49.
TABLE 4 KEY REGULATORY REQUIREMENTS FOR CLEANING VALIDATION OF DOWNSTREAM PURIFICATION PROCESSES 51.
TABLE 5 COMPARISON OF ALTERNATIVE DOWNSTREAM PURIFICATION TECHNIQUES 57.
TABLE 6 MEMBRANE CHROMATOGRAPHY MARKET: IMPACT OF PORTER’S FIVE FORCES 61.
TABLE 7 MEMBRANE CHROMATOGRAPHY MARKET: ROLE IN ECOSYSTEM 67.
TABLE 8 AVERAGE SELLING PRICE TREND OF MEMBRANE CHROMATOGRAPHY PRODUCTS, BY KEY PLAYER, 2023–2025 68.
TABLE 9 AVERAGE SELLING PRICE TREND OF MEMBRANE CHROMATOGRAPHY PRODUCTS, BY REGION,.
2023–2025 (USD) 69.
TABLE 10 IMPORT DATA FOR HS CODE 842129, 2021–2025 (USD THOUSAND) 70.
TABLE 11 IMPORT DATA FOR HS CODE 842129, 2021–2025 (TONS) 71.
TABLE 12 EXPORT DATA FOR HS CODE 842129, 2021–2025 (USD THOUSAND) 72.
TABLE 13 EXPORT DATA FOR HS CODE 842129, 2021–2025 (TONS) 72.
TABLE 14 MEMBRANE CHROMATOGRAPHY MARKET: KEY CONFERENCES & EVENTS, 2026–2027 73.
TABLE 15 US ADJUSTED RECIPROCAL TARIFF RATES 76.
TABLE 16 IMPACT ON END-USE APPLICATIONS 79.
TABLE 17 ADVANTAGES OF SINGLE-USE MEMBRANE CHROMATOGRAPHY OVER CONVENTIONAL PACKED-BED CHROMATOGRAPHY 82.
TABLE 18 ADVANTAGES AND DISADVANTAGES OF MONOLITH CHROMATOGRAPHY 84.
TABLE 19 MEMBRANE CHROMATOGRAPHY MARKET: INDICATIVE LIST OF PATENTS, 2026 87.
TABLE 20 CASE STUDIES OF AI IMPLEMENTATION IN MEMBRANE CHROMATOGRAPHY MARKET 91.
TABLE 21 CLIENTS’ READINESS TO ADOPT GENERATIVE AI IN MEMBRANE CHROMATOGRAPHY 92.
TABLE 22 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 93.
TABLE 23 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 94.
TABLE 24 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 95.
TABLE 25 REST OF THE WORLD: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 96.
TABLE 26 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS, BY PRODUCT 101.
TABLE 27 KEY BUYING CRITERIA, BY END USER 102.
TABLE 28 MEMBRANE CHROMATOGRAPHY MARKET, BY PRODUCT, 2023–2031 (USD MILLION) 105.
TABLE 29 MEMBRANE CHROMATOGRAPHY MARKET, BY PRODUCT, 2023–2031 (THOUSAND UNITS) 105.
TABLE 30 CAPSULES, CASSETTES, AND CARTRIDGES MARKET, BY REGION, 2023–2031 (USD MILLION) 106.
TABLE 31 NORTH AMERICA: CAPSULES, CASSETTES, AND CARTRIDGES MARKET, BY COUNTRY,.
2023–2031 (USD MILLION) 107.
TABLE 32 EUROPE: CAPSULES, CASSETTES, AND CARTRIDGES MARKET, BY COUNTRY, 2023–2031 (USD MILLION) 107.
TABLE 33 ASIA PACIFIC: CAPSULES, CASSETTES, AND CARTRIDGES MARKET, BY COUNTRY, 2023–2031 (USD MILLION) 107.
TABLE 34 LATIN AMERICA: CAPSULES, CASSETTES, AND CARTRIDGES MARKET, BY COUNTRY,.
2023–2031 (USD MILLION) 108.
TABLE 35 MIDDLE EAST: CAPSULES, CASSETTES, AND CARTRIDGES MARKET, BY REGION, 2023–2031 (USD MILLION) 108.
TABLE 36 GCC COUNTRIES: CAPSULES, CASSETTES, AND CARTRIDGES MARKET, BY COUNTRY,.
2023–2031 (USD MILLION) 108.
TABLE 37 SYRINGE FILTERS MARKET, BY REGION, 2023–2031 (USD MILLION) 109.
TABLE 38 NORTH AMERICA: SYRINGE FILTERS MARKET, BY COUNTRY, 2023–2031 (USD MILLION) 109.
TABLE 39 EUROPE: SYRINGE FILTERS MARKET, BY COUNTRY, 2023–2031 (USD MILLION) 110.
TABLE 40 ASIA PACIFIC: SYRINGE FILTERS MARKET, BY COUNTRY, 2023–2031 (USD MILLION) 110.
TABLE 41 LATIN AMERICA: SYRINGE FILTERS MARKET, BY COUNTRY, 2023–2031 (USD MILLION) 110.
TABLE 42 MIDDLE EAST: SYRINGE FILTERS MARKET, BY REGION, 2023–2031 (USD MILLION) 111.
TABLE 43 GCC COUNTRIES: SYRINGE FILTERS MARKET, BY COUNTRY, 2023–2031 (USD MILLION) 111.
TABLE 44 FILTER PLATES MARKET, BY REGION, 2023–2031 (USD MILLION) 112.
TABLE 45 NORTH AMERICA: FILTER PLATES MARKET, BY COUNTRY, 2023–2031 (USD MILLION) 112.
TABLE 46 EUROPE: FILTER PLATES MARKET, BY COUNTRY, 2023–2031 (USD MILLION) 112.
TABLE 47 ASIA PACIFIC: FILTER PLATES MARKET, BY COUNTRY, 2023–2031 (USD MILLION) 113.
TABLE 48 LATIN AMERICA: FILTER PLATES MARKET, BY COUNTRY, 2023–2031 (USD MILLION) 113.
TABLE 49 MIDDLE EAST: FILTER PLATES MARKET, BY REGION, 2023–2031 (USD MILLION) 113.
TABLE 50 GCC COUNTRIES: FILTER PLATES MARKET, BY COUNTRY, 2023–2031 (USD MILLION) 114.
TABLE 51 SPIN COLUMNS MARKET, BY REGION, 2023–2031 (USD MILLION) 114.
TABLE 52 NORTH AMERICA: SPIN COLUMNS MARKET, BY COUNTRY, 2023–2031 (USD MILLION) 115.
TABLE 53 EUROPE: SPIN COLUMNS MARKET, BY COUNTRY, 2023–2031 (USD MILLION) 115.
TABLE 54 ASIA PACIFIC: SPIN COLUMNS MARKET, BY COUNTRY, 2023–2031 (USD MILLION) 115.
TABLE 55 LATIN AMERICA: SPIN COLUMNS MARKET, BY COUNTRY, 2023–2031 (USD MILLION) 116.
TABLE 56 MIDDLE EAST: SPIN COLUMNS MARKET, BY REGION, 2023–2031 (USD MILLION) 116.
TABLE 57 GCC COUNTRIES: SPIN COLUMNS MARKET, BY COUNTRY, 2023–2031 (USD MILLION) 116.
TABLE 58 MEMBRANE DISCS & SHEETS MARKET, BY REGION, 2023–2031 (USD MILLION) 117.
TABLE 59 NORTH AMERICA: MEMBRANE DISCS & SHEETS MARKET, BY COUNTRY, 2023–2031 (USD MILLION) 118.
TABLE 60 EUROPE: MEMBRANE DISCS & SHEETS MARKET, BY COUNTRY, 2023–2031 (USD MILLION) 118.
TABLE 61 ASIA PACIFIC: MEMBRANE DISCS & SHEETS MARKET, BY COUNTRY, 2023–2031 (USD MILLION) 118.
TABLE 62 LATIN AMERICA: MEMBRANE DISCS & SHEETS MARKET, BY COUNTRY, 2023–2031 (USD MILLION) 119.
TABLE 63 MIDDLE EAST: MEMBRANE DISCS & SHEETS MARKET, BY REGION, 2023–2031 (USD MILLION) 119.
TABLE 64 GCC COUNTRIES: MEMBRANE DISCS & SHEETS MARKET, BY COUNTRY, 2023–2031 (USD MILLION) 119.
TABLE 65 OTHER CONSUMABLES & ACCESSORIES MARKET, BY REGION, 2023–2031 (USD MILLION) 120.
TABLE 66 NORTH AMERICA: OTHER CONSUMABLES & ACCESSORIES MARKET, BY COUNTRY,.
2023–2031 (USD MILLION) 120.
TABLE 67 EUROPE: OTHER CONSUMABLES & ACCESSORIES MARKET, BY COUNTRY, 2023–2031 (USD MILLION) 121.
TABLE 68 ASIA PACIFIC: OTHER CONSUMABLES & ACCESSORIES MARKET, BY COUNTRY, 2023–2031 (USD MILLION) 121.
TABLE 69 LATIN AMERICA: OTHER CONSUMABLES & ACCESSORIES MARKET, BY COUNTRY, 2023–2031 (USD MILLION) 122.
TABLE 70 MIDDLE EAST: OTHER CONSUMABLES & ACCESSORIES MARKET, BY REGION, 2023–2031 (USD MILLION) 122.
TABLE 71 GCC COUNTRIES: OTHER CONSUMABLES & ACCESSORIES MARKET, BY COUNTRY, 2023–2031 (USD MILLION) 122.
TABLE 72 MEMBRANE CHROMATOGRAPHY MARKET, BY TECHNIQUE, 2023–2031 (USD MILLION) 124.
TABLE 73 ION EXCHANGE MEMBRANE CHROMATOGRAPHY MARKET, BY TYPE, 2023–2031 (USD MILLION) 125.
TABLE 74 ION EXCHANGE MEMBRANE CHROMATOGRAPHY MARKET, BY REGION, 2023–2031 (USD MILLION) 125.
TABLE 75 NORTH AMERICA: ION EXCHANGE MEMBRANE CHROMATOGRAPHY MARKET, BY COUNTRY,.
2023–2031 (USD MILLION) 125.
TABLE 76 EUROPE: ION EXCHANGE MEMBRANE CHROMATOGRAPHY MARKET, BY COUNTRY,.
2023–2031 (USD MILLION) 126.
TABLE 77 ASIA PACIFIC: ION EXCHANGE MEMBRANE CHROMATOGRAPHY MARKET, BY COUNTRY,.
2023–2031 (USD MILLION) 126.
TABLE 78 LATIN AMERICA: ION EXCHANGE MEMBRANE CHROMATOGRAPHY MARKET, BY COUNTRY,.
2023–2031 (USD MILLION) 127.
TABLE 79 MIDDLE EAST: ION EXCHANGE MEMBRANE CHROMATOGRAPHY MARKET, BY REGION,.
2023–2031 (USD MILLION) 127.
TABLE 80 GCC COUNTRIES: ION EXCHANGE MEMBRANE CHROMATOGRAPHY MARKET, BY COUNTRY,.
2023–2031 (USD MILLION) 127.
TABLE 81 ANION EXCHANGE CHROMATOGRAPHY MEMBRANES: LIGAND FUNCTIONAL GROUPS 128.
TABLE 82 ANION EXCHANGE MEMBRANE CHROMATOGRAPHY MARKET, BY REGION, 2023–2031 (USD MILLION) 129.
TABLE 83 NORTH AMERICA: ANION EXCHANGE MEMBRANE CHROMATOGRAPHY MARKET, BY COUNTRY,.
2023–2031 (USD MILLION) 129.
TABLE 84 EUROPE: ANION EXCHANGE MEMBRANE CHROMATOGRAPHY MARKET, BY COUNTRY,.
2023–2031 (USD MILLION) 129.
TABLE 85 ASIA PACIFIC: ANION EXCHANGE MEMBRANE CHROMATOGRAPHY MARKET, BY COUNTRY,.
2023–2031 (USD MILLION) 130.
TABLE 86 LATIN AMERICA: ANION EXCHANGE MEMBRANE CHROMATOGRAPHY MARKET, BY COUNTRY,.
2023–2031 (USD MILLION) 130.
TABLE 87 MIDDLE EAST: ANION EXCHANGE MEMBRANE CHROMATOGRAPHY MARKET, BY REGION,.
2023–2031 (USD MILLION) 130.
TABLE 88 GCC COUNTRIES: ANION EXCHANGE MEMBRANE CHROMATOGRAPHY MARKET, BY COUNTRY,.
2023–2031 (USD MILLION) 131.
TABLE 89 CATION EXCHANGE CHROMATOGRAPHY MEMBRANES: LIGAND FUNCTIONAL GROUPS 131.
TABLE 90 CATION EXCHANGE MEMBRANE CHROMATOGRAPHY MARKET, BY REGION, 2023–2031 (USD MILLION) 132.
TABLE 91 NORTH AMERICA: CATION EXCHANGE MEMBRANE CHROMATOGRAPHY MARKET, BY COUNTRY,.
2023–2031 (USD MILLION) 132.
TABLE 92 EUROPE: CATION EXCHANGE MEMBRANE CHROMATOGRAPHY MARKET, BY COUNTRY,.
2023–2031 (USD MILLION) 132.
TABLE 93 ASIA PACIFIC: CATION EXCHANGE MEMBRANE CHROMATOGRAPHY MARKET, BY COUNTRY,.
2023–2031 (USD MILLION) 133.
TABLE 94 LATIN AMERICA: CATION EXCHANGE MEMBRANE CHROMATOGRAPHY MARKET, BY COUNTRY,.
2023–2031 (USD MILLION) 133.
TABLE 95 MIDDLE EAST: CATION EXCHANGE MEMBRANE CHROMATOGRAPHY MARKET, BY REGION,.
2023–2031 (USD MILLION) 133.
TABLE 96 GCC COUNTRIES: CATION EXCHANGE MEMBRANE CHROMATOGRAPHY MARKET, BY COUNTRY,.
2023–2031 (USD MILLION) 134.
TABLE 97 AFFINITY MEMBRANE CHROMATOGRAPHY MARKET, BY REGION, 2023–2031 (USD MILLION) 134.
TABLE 98 NORTH AMERICA: AFFINITY MEMBRANE CHROMATOGRAPHY MARKET, BY COUNTRY,.
2023–2031 (USD MILLION) 135.
TABLE 99 EUROPE: AFFINITY MEMBRANE CHROMATOGRAPHY MARKET, BY COUNTRY, 2023–2031 (USD MILLION) 135.
TABLE 100 ASIA PACIFIC: AFFINITY MEMBRANE CHROMATOGRAPHY MARKET, BY COUNTRY, 2023–2031 (USD MILLION) 135.
TABLE 101 LATIN AMERICA: AFFINITY MEMBRANE CHROMATOGRAPHY MARKET, BY COUNTRY,.
2023–2031 (USD MILLION) 136.
TABLE 102 MIDDLE EAST: AFFINITY MEMBRANE CHROMATOGRAPHY MARKET, BY REGION, 2023–2031 (USD MILLION) 136.
TABLE 103 GCC COUNTRIES: AFFINITY MEMBRANE CHROMATOGRAPHY MARKET, BY COUNTRY,.
2023–2031 (USD MILLION) 136.
TABLE 104 HYDROPHOBIC INTERACTION MEMBRANE CHROMATOGRAPHY MARKET, BY REGION,.
2023–2031 (USD MILLION) 137.
TABLE 105 NORTH AMERICA: HYDROPHOBIC INTERACTION MEMBRANE CHROMATOGRAPHY MARKET, BY COUNTRY,.
2023–2031 (USD MILLION) 138.
TABLE 106 EUROPE: HYDROPHOBIC INTERACTION MEMBRANE CHROMATOGRAPHY MARKET, BY COUNTRY,.
2023–2031 (USD MILLION) 138.
TABLE 107 ASIA PACIFIC: HYDROPHOBIC INTERACTION MEMBRANE CHROMATOGRAPHY MARKET, BY COUNTRY,.
2023–2031 (USD MILLION) 138.
TABLE 108 LATIN AMERICA: HYDROPHOBIC INTERACTION MEMBRANE CHROMATOGRAPHY MARKET, BY COUNTRY,.
2023–2031 (USD MILLION) 139.
TABLE 109 MIDDLE EAST: HYDROPHOBIC INTERACTION MEMBRANE CHROMATOGRAPHY MARKET, BY REGION,.
2023–2031 (USD MILLION) 139.
TABLE 110 GCC COUNTRIES: HYDROPHOBIC INTERACTION MEMBRANE CHROMATOGRAPHY MARKET, BY COUNTRY,.
2023–2031 (USD MILLION) 139.
TABLE 111 MEMBRANE CHROMATOGRAPHY MARKET, BY OPERATION MODE, 2023–2031 (USD MILLION) 141.
TABLE 112 FLOW-THROUGH MEMBRANE CHROMATOGRAPHY MARKET, BY REGION, 2023–2031 (USD MILLION) 142.
TABLE 113 NORTH AMERICA: FLOW-THROUGH MEMBRANE CHROMATOGRAPHY MARKET, BY COUNTRY,.
2023–2031 (USD MILLION) 142.
TABLE 114 EUROPE: FLOW-THROUGH MEMBRANE CHROMATOGRAPHY MARKET, BY COUNTRY,.
2023–2031 (USD MILLION) 142.
TABLE 115 ASIA PACIFIC: FLOW-THROUGH MEMBRANE CHROMATOGRAPHY MARKET, BY COUNTRY,.
2023–2031 (USD MILLION) 143.
TABLE 116 LATIN AMERICA: FLOW-THROUGH MEMBRANE CHROMATOGRAPHY MARKET, BY COUNTRY,.
2023–2031 (USD MILLION) 143.
TABLE 117 MIDDLE EAST: FLOW-THROUGH MEMBRANE CHROMATOGRAPHY MARKET, BY REGION,.
2023–2031 (USD MILLION) 143.
TABLE 118 GCC COUNTRIES: FLOW-THROUGH MEMBRANE CHROMATOGRAPHY MARKET, BY COUNTRY,.
2023–2031 (USD MILLION) 144.
TABLE 119 BIND-ELUTE MEMBRANE CHROMATOGRAPHY MARKET, BY REGION, 2023–2031 (USD MILLION) 144.
TABLE 120 NORTH AMERICA: BIND-ELUTE MEMBRANE CHROMATOGRAPHY MARKET, BY COUNTRY,.
2023–2031 (USD MILLION) 145.
TABLE 121 EUROPE: BIND-ELUTE MEMBRANE CHROMATOGRAPHY MARKET, BY COUNTRY, 2023–2031 (USD MILLION) 145.
TABLE 122 ASIA PACIFIC: BIND-ELUTE MEMBRANE CHROMATOGRAPHY MARKET, BY COUNTRY,.
2023–2031 (USD MILLION) 145.
TABLE 123 LATIN AMERICA: BIND-ELUTE MEMBRANE CHROMATOGRAPHY MARKET, BY COUNTRY,.
2023–2031 (USD MILLION) 146.
TABLE 124 MIDDLE EAST: BIND-ELUTE MEMBRANE CHROMATOGRAPHY MARKET, BY REGION,.
2023–2031 (USD MILLION) 146.
TABLE 125 GCC COUNTRIES: BIND-ELUTE MEMBRANE CHROMATOGRAPHY MARKET, BY COUNTRY,.
2023–2031 (USD MILLION) 146.
TABLE 126 MEMBRANE CHROMATOGRAPHY MARKET, BY MEMBRANE MATERIAL, 2023–2031 (USD MILLION) 148.
TABLE 127 EXAMPLES OF POLYETHERSULFONE (PES) MEMBRANE CHROMATOGRAPHY PRODUCTS 149.
TABLE 128 MEMBRANE CHROMATOGRAPHY MARKET FOR POLYETHERSULFONE, BY REGION, 2023–2031 (USD MILLION) 149.
TABLE 129 NORTH AMERICA: MEMBRANE CHROMATOGRAPHY MARKET FOR POLYETHERSULFONE, BY COUNTRY,.
2023–2031 (USD MILLION) 150.
TABLE 130 EUROPE: MEMBRANE CHROMATOGRAPHY MARKET FOR POLYETHERSULFONE, BY COUNTRY,.
2023–2031 (USD MILLION) 150.
TABLE 131 ASIA PACIFIC: MEMBRANE CHROMATOGRAPHY MARKET FOR POLYETHERSULFONE, BY COUNTRY,.
2023–2031 (USD MILLION) 150.
TABLE 132 LATIN AMERICA: MEMBRANE CHROMATOGRAPHY MARKET FOR POLYETHERSULFONE, BY COUNTRY,.
2023–2031 (USD MILLION) 151.
TABLE 133 MIDDLE EAST: MEMBRANE CHROMATOGRAPHY MARKET FOR POLYETHERSULFONE, BY REGION,.
2023–2031 (USD MILLION) 151.
TABLE 134 GCC COUNTRIES: MEMBRANE CHROMATOGRAPHY MARKET FOR POLYETHERSULFONE, BY COUNTRY,.
2023–2031 (USD MILLION) 151.
TABLE 135 EXAMPLES OF CELLULOSE MEMBRANE CHROMATOGRAPHY PRODUCTS 152.
TABLE 136 MEMBRANE CHROMATOGRAPHY MARKET FOR CELLULOSE, BY REGION, 2023–2031 (USD MILLION) 153.
TABLE 137 NORTH AMERICA: MEMBRANE CHROMATOGRAPHY MARKET FOR CELLULOSE, BY COUNTRY,.
2023–2031 (USD MILLION) 153.
TABLE 138 EUROPE: MEMBRANE CHROMATOGRAPHY MARKET FOR CELLULOSE, BY COUNTRY,.
2023–2031 (USD MILLION) 153.
TABLE 139 ASIA PACIFIC: MEMBRANE CHROMATOGRAPHY MARKET FOR CELLULOSE, BY COUNTRY,.
2023–2031 (USD MILLION) 154.
TABLE 140 LATIN AMERICA: MEMBRANE CHROMATOGRAPHY MARKET FOR CELLULOSE, BY COUNTRY,.
2023–2031 (USD MILLION) 154.
TABLE 141 MIDDLE EAST: MEMBRANE CHROMATOGRAPHY MARKET FOR CELLULOSE, BY REGION,.
2023–2031 (USD MILLION) 154.
TABLE 142 GCC COUNTRIES: MEMBRANE CHROMATOGRAPHY MARKET FOR CELLULOSE, BY COUNTRY,.
2023–2031 (USD MILLION) 155.
TABLE 143 EXAMPLES OF HYDROGEL MEMBRANE CHROMATOGRAPHY PRODUCTS 155.
TABLE 144 MEMBRANE CHROMATOGRAPHY MARKET FOR HYDROGEL, BY REGION, 2023–2031 (USD MILLION) 156.
TABLE 145 NORTH AMERICA: MEMBRANE CHROMATOGRAPHY MARKET FOR HYDROGEL, BY COUNTRY,.
2023–2031 (USD MILLION) 156.
TABLE 146 EUROPE: MEMBRANE CHROMATOGRAPHY MARKET FOR HYDROGEL, BY COUNTRY,.
2023–2031 (USD MILLION) 156.
TABLE 147 ASIA PACIFIC: MEMBRANE CHROMATOGRAPHY MARKET FOR HYDROGEL, BY COUNTRY,.
2023–2031 (USD MILLION) 157.
TABLE 148 LATIN AMERICA: MEMBRANE CHROMATOGRAPHY MARKET FOR HYDROGEL, BY COUNTRY,.
2023–2031 (USD MILLION) 157.
TABLE 149 MIDDLE EAST: MEMBRANE CHROMATOGRAPHY MARKET FOR HYDROGEL, BY REGION,.
2023–2031 (USD MILLION) 157.
TABLE 150 GCC COUNTRIES: MEMBRANE CHROMATOGRAPHY MARKET FOR HYDROGEL, BY COUNTRY,.
2023–2031 (USD MILLION) 158.
TABLE 151 MEMBRANE CHROMATOGRAPHY MARKET FOR OTHER MEMBRANE MATERIALS, BY REGION,.
2023–2031 (USD MILLION) 159.
TABLE 152 NORTH AMERICA: MEMBRANE CHROMATOGRAPHY MARKET FOR OTHER MEMBRANE MATERIALS, BY COUNTRY, 2023–2031 (USD MILLION) 159.
TABLE 153 EUROPE: MEMBRANE CHROMATOGRAPHY MARKET FOR OTHER MEMBRANE MATERIALS, BY COUNTRY,.
2023–2031 (USD MILLION) 159.
TABLE 154 ASIA PACIFIC: MEMBRANE CHROMATOGRAPHY MARKET FOR OTHER MEMBRANE MATERIALS, BY COUNTRY, 2023–2031 (USD MILLION) 160.
TABLE 155 LATIN AMERICA: MEMBRANE CHROMATOGRAPHY MARKET FOR OTHER MEMBRANE MATERIALS, BY COUNTRY, 2023–2031 (USD MILLION) 160.
TABLE 156 MIDDLE EAST: MEMBRANE CHROMATOGRAPHY MARKET FOR OTHER MEMBRANE MATERIALS, BY REGION,.
2023–2031 (USD MILLION) 160.
TABLE 157 GCC COUNTRIES: MEMBRANE CHROMATOGRAPHY MARKET FOR OTHER MEMBRANE MATERIALS, BY COUNTRY, 2023–2031 (USD MILLION) 161.
TABLE 158 MEMBRANE CHROMATOGRAPHY MARKET, BY END USER, 2023–2031 (USD MILLION) 163.
TABLE 159 MEMBRANE CHROMATOGRAPHY MARKET FOR PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES,.
BY REGION, 2023–2031 (USD MILLION) 164.
TABLE 160 NORTH AMERICA: MEMBRANE CHROMATOGRAPHY MARKET FOR PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES, BY COUNTRY, 2023–2031 (USD MILLION) 164.
TABLE 161 EUROPE: MEMBRANE CHROMATOGRAPHY MARKET FOR PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES, BY COUNTRY, 2023–2031 (USD MILLION) 164.
TABLE 162 ASIA PACIFIC: MEMBRANE CHROMATOGRAPHY MARKET FOR PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES, BY COUNTRY, 2023–2031 (USD MILLION) 165.
TABLE 163 LATIN AMERICA: MEMBRANE CHROMATOGRAPHY MARKET FOR PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES, BY COUNTRY, 2023–2031 (USD MILLION) 165.
TABLE 164 MIDDLE EAST: MEMBRANE CHROMATOGRAPHY MARKET FOR PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES, BY REGION, 2023–2031 (USD MILLION) 165.
TABLE 165 GCC COUNTRIES: MEMBRANE CHROMATOGRAPHY MARKET FOR PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES, BY COUNTRY, 2023–2031 (USD MILLION) 166.
TABLE 166 MEMBRANE CHROMATOGRAPHY MARKET FOR CROS & CDMOS, BY REGION, 2023–2031 (USD MILLION) 167.
TABLE 167 NORTH AMERICA: MEMBRANE CHROMATOGRAPHY MARKET FOR CROS & CDMOS, BY COUNTRY,.
2023–2031 (USD MILLION) 167.
TABLE 168 EUROPE: MEMBRANE CHROMATOGRAPHY MARKET FOR CROS & CDMOS, BY COUNTRY,.
2023–2031 (USD MILLION) 167.
TABLE 169 ASIA PACIFIC: MEMBRANE CHROMATOGRAPHY MARKET FOR CROS & CDMOS, BY COUNTRY,.
2023–2031 (USD MILLION) 168.
TABLE 170 LATIN AMERICA: MEMBRANE CHROMATOGRAPHY MARKET FOR CROS & CDMOS, BY COUNTRY,.
2023–2031 (USD MILLION) 168.
TABLE 171 MIDDLE EAST: MEMBRANE CHROMATOGRAPHY MARKET FOR CROS & CDMOS, BY REGION,.
2023–2031 (USD MILLION) 168.
TABLE 172 GCC COUNTRIES: MEMBRANE CHROMATOGRAPHY MARKET FOR CROS & CDMOS, BY COUNTRY,.
2023–2031 (USD MILLION) 169.
TABLE 173 MEMBRANE CHROMATOGRAPHY MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION,.
2023–2031 (USD MILLION) 170.
TABLE 174 NORTH AMERICA: MEMBRANE CHROMATOGRAPHY MARKET FOR ACADEMIC & RESEARCH INSTITUTES,.
BY COUNTRY, 2023–2031 (USD MILLION) 170.
TABLE 175 EUROPE: MEMBRANE CHROMATOGRAPHY MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2023–2031 (USD MILLION) 170.
TABLE 176 ASIA PACIFIC: MEMBRANE CHROMATOGRAPHY MARKET FOR ACADEMIC & RESEARCH INSTITUTES,.
BY COUNTRY, 2023–2031 (USD MILLION) 171.
TABLE 177 LATIN AMERICA: MEMBRANE CHROMATOGRAPHY MARKET FOR ACADEMIC & RESEARCH INSTITUTES,.
BY COUNTRY, 2023–2031 (USD MILLION) 171.
TABLE 178 MIDDLE EAST: MEMBRANE CHROMATOGRAPHY MARKET FOR ACADEMIC & RESEARCH INSTITUTES,.
BY REGION, 2023–2031 (USD MILLION) 171.
TABLE 179 GCC COUNTRIES: MEMBRANE CHROMATOGRAPHY MARKET FOR ACADEMIC & RESEARCH INSTITUTES,.
BY COUNTRY, 2023–2031 (USD MILLION) 172.
TABLE 180 MEMBRANE CHROMATOGRAPHY MARKET, BY REGION, 2023–2031 (USD MILLION) 174.
TABLE 181 US: THERAPEUTIC MONOCLONAL ANTIBODIES APPROVED, 2023–2025 175.
TABLE 182 NORTH AMERICA: MEMBRANE CHROMATOGRAPHY MARKET, BY COUNTRY, 2023–2031 (USD MILLION) 176.
TABLE 183 NORTH AMERICA: MEMBRANE CHROMATOGRAPHY MARKET, BY PRODUCT, 2023–2031 (USD MILLION) 176.
TABLE 184 NORTH AMERICA: MEMBRANE CHROMATOGRAPHY MARKET, BY TECHNIQUE, 2023–2031 (USD MILLION) 176.
TABLE 185 NORTH AMERICA: ION EXCHANGE MEMBRANE CHROMATOGRAPHY MARKET, BY TYPE,.
2023–2031 (USD MILLION) 177.
TABLE 186 NORTH AMERICA: MEMBRANE CHROMATOGRAPHY MARKET, BY OPERATION MODE,.
2023–2031 (USD MILLION) 177.
TABLE 187 NORTH AMERICA: MEMBRANE CHROMATOGRAPHY MARKET, BY MEMBRANE MATERIAL,.
2023–2031 (USD MILLION) 177.
TABLE 188 NORTH AMERICA: MEMBRANE CHROMATOGRAPHY MARKET, BY END USER, 2023–2031 (USD MILLION) 178.
TABLE 189 US: MEMBRANE CHROMATOGRAPHY MARKET, BY PRODUCT, 2023–2031 (USD MILLION) 179.
TABLE 190 US: MEMBRANE CHROMATOGRAPHY MARKET, BY TECHNIQUE, 2023–2031 (USD MILLION) 180.
TABLE 191 US: ION EXCHANGE MEMBRANE CHROMATOGRAPHY MARKET, BY TYPE, 2023–2031 (USD MILLION) 180.
TABLE 192 US: MEMBRANE CHROMATOGRAPHY MARKET, BY OPERATION MODE, 2023–2031 (USD MILLION) 180.
TABLE 193 US: MEMBRANE CHROMATOGRAPHY MARKET, BY MEMBRANE MATERIAL, 2023–2031 (USD MILLION) 181.
TABLE 194 US: MEMBRANE CHROMATOGRAPHY MARKET, BY END USER, 2023–2031 (USD MILLION) 181.
TABLE 195 CANADA: MEMBRANE CHROMATOGRAPHY MARKET, BY PRODUCT, 2023–2031 (USD MILLION) 182.
TABLE 196 CANADA: MEMBRANE CHROMATOGRAPHY MARKET, BY TECHNIQUE, 2023–2031 (USD MILLION) 182.
TABLE 197 CANADA: ION EXCHANGE MEMBRANE CHROMATOGRAPHY MARKET, BY TYPE, 2023–2031 (USD MILLION) 183.
TABLE 198 CANADA: MEMBRANE CHROMATOGRAPHY MARKET, BY OPERATION MODE, 2023–2031 (USD MILLION) 183.
TABLE 199 CANADA: MEMBRANE CHROMATOGRAPHY MARKET, BY MEMBRANE MATERIAL, 2023–2031 (USD MILLION) 183.
TABLE 200 CANADA: MEMBRANE CHROMATOGRAPHY MARKET, BY END USER, 2023–2031 (USD MILLION) 184.
TABLE 201 EUROPE: LIST OF APPROVED MONOCLONAL ANTIBODY TREATMENTS 184.
TABLE 202 EUROPE: MEMBRANE CHROMATOGRAPHY MARKET, BY COUNTRY, 2023–2031 (USD MILLION) 185.
TABLE 203 EUROPE: MEMBRANE CHROMATOGRAPHY MARKET, BY PRODUCT, 2023–2031 (USD MILLION) 185.
TABLE 204 EUROPE: MEMBRANE CHROMATOGRAPHY MARKET, BY TECHNIQUE, 2023–2031 (USD MILLION) 186.
TABLE 205 EUROPE: ION EXCHANGE MEMBRANE CHROMATOGRAPHY MARKET, BY TYPE, 2023–2031 (USD MILLION) 186.
TABLE 206 EUROPE: MEMBRANE CHROMATOGRAPHY MARKET, BY OPERATION MODE, 2023–2031 (USD MILLION) 186.
TABLE 207 EUROPE: MEMBRANE CHROMATOGRAPHY MARKET, BY MEMBRANE MATERIAL, 2023–2031 (USD MILLION) 187.
TABLE 208 EUROPE: MEMBRANE CHROMATOGRAPHY MARKET, BY END USER, 2023–2031 (USD MILLION) 187.
TABLE 209 GERMANY: MEMBRANE CHROMATOGRAPHY MARKET, BY PRODUCT, 2023–2031 (USD MILLION) 188.
TABLE 210 GERMANY: MEMBRANE CHROMATOGRAPHY MARKET, BY TECHNIQUE, 2023–2031 (USD MILLION) 188.
TABLE 211 GERMANY: ION EXCHANGE MEMBRANE CHROMATOGRAPHY MARKET, BY TYPE, 2023–2031 (USD MILLION) 189.
TABLE 212 GERMANY: MEMBRANE CHROMATOGRAPHY MARKET, BY OPERATION MODE, 2023–2031 (USD MILLION) 189.
TABLE 213 GERMANY: MEMBRANE CHROMATOGRAPHY MARKET, BY MEMBRANE MATERIAL, 2023–2031 (USD MILLION) 189.
TABLE 214 GERMANY: MEMBRANE CHROMATOGRAPHY MARKET, BY END USER, 2023–2031 (USD MILLION) 190.
TABLE 215 UK: MEMBRANE CHROMATOGRAPHY MARKET, BY PRODUCT, 2023–2031 (USD MILLION) 190.
TABLE 216 UK: MEMBRANE CHROMATOGRAPHY MARKET, BY TECHNIQUE, 2023–2031 (USD MILLION) 191.
TABLE 217 UK: ION EXCHANGE MEMBRANE CHROMATOGRAPHY MARKET, BY TYPE, 2023–2031 (USD MILLION) 191.
TABLE 218 UK: MEMBRANE CHROMATOGRAPHY MARKET, BY OPERATION MODE, 2023–2031 (USD MILLION) 191.
TABLE 219 UK: MEMBRANE CHROMATOGRAPHY MARKET, BY MEMBRANE MATERIAL, 2023–2031 (USD MILLION) 192.
TABLE 220 UK: MEMBRANE CHROMATOGRAPHY MARKET, BY END USER, 2023–2031 (USD MILLION) 192.
TABLE 221 FRANCE: MEMBRANE CHROMATOGRAPHY MARKET, BY PRODUCT, 2023–2031 (USD MILLION) 193.
TABLE 222 FRANCE: MEMBRANE CHROMATOGRAPHY MARKET, BY TECHNIQUE, 2023–2031 (USD MILLION) 193.
TABLE 223 FRANCE: ION EXCHANGE MEMBRANE CHROMATOGRAPHY MARKET, BY TYPE, 2023–2031 (USD MILLION) 193.
TABLE 224 FRANCE: MEMBRANE CHROMATOGRAPHY MARKET, BY OPERATION MODE, 2023–2031 (USD MILLION) 194.
TABLE 225 FRANCE: MEMBRANE CHROMATOGRAPHY MARKET, BY MEMBRANE MATERIAL, 2023–2031 (USD MILLION) 194.
TABLE 226 FRANCE: MEMBRANE CHROMATOGRAPHY MARKET, BY END USER, 2023–2031 (USD MILLION) 194.
TABLE 227 ITALY: MEMBRANE CHROMATOGRAPHY MARKET, BY PRODUCT, 2023–2031 (USD MILLION) 195.
TABLE 228 ITALY: MEMBRANE CHROMATOGRAPHY MARKET, BY TECHNIQUE, 2023–2031 (USD MILLION) 195.
TABLE 229 ITALY: ION EXCHANGE MEMBRANE CHROMATOGRAPHY MARKET, BY TYPE, 2023–2031 (USD MILLION) 196.
TABLE 230 ITALY: MEMBRANE CHROMATOGRAPHY MARKET, BY OPERATION MODE, 2023–2031 (USD MILLION) 196.
TABLE 231 ITALY: MEMBRANE CHROMATOGRAPHY MARKET, BY MEMBRANE MATERIAL, 2023–2031 (USD MILLION) 196.
TABLE 232 ITALY: MEMBRANE CHROMATOGRAPHY MARKET, BY END USER, 2023–2031 (USD MILLION) 197.
TABLE 233 SPAIN: MEMBRANE CHROMATOGRAPHY MARKET, BY PRODUCT, 2023–2031 (USD MILLION) 197.
TABLE 234 SPAIN: MEMBRANE CHROMATOGRAPHY MARKET, BY TECHNIQUE, 2023–2031 (USD MILLION) 198.
TABLE 235 SPAIN: ION EXCHANGE MEMBRANE CHROMATOGRAPHY MARKET, BY TYPE, 2023–2031 (USD MILLION) 198.
TABLE 236 SPAIN: MEMBRANE CHROMATOGRAPHY MARKET, BY OPERATION MODE, 2023–2031 (USD MILLION) 198.
TABLE 237 SPAIN: MEMBRANE CHROMATOGRAPHY MARKET, BY MEMBRANE MATERIAL, 2023–2031 (USD MILLION) 199.
TABLE 238 SPAIN: MEMBRANE CHROMATOGRAPHY MARKET, BY END USER, 2023–2031 (USD MILLION) 199.
TABLE 239 REST OF EUROPE: MEMBRANE CHROMATOGRAPHY MARKET, BY PRODUCT, 2023–2031 (USD MILLION) 200.
TABLE 240 REST OF EUROPE: MEMBRANE CHROMATOGRAPHY MARKET, BY TECHNIQUE, 2023–2031 (USD MILLION) 200.
TABLE 241 REST OF EUROPE: ION EXCHANGE MEMBRANE CHROMATOGRAPHY MARKET, BY TYPE,.
2023–2031 (USD MILLION) 200.
TABLE 242 REST OF EUROPE: MEMBRANE CHROMATOGRAPHY MARKET, BY OPERATION MODE,.
2023–2031 (USD MILLION) 201.
TABLE 243 REST OF EUROPE: MEMBRANE CHROMATOGRAPHY MARKET, BY MEMBRANE MATERIAL,.
2023–2031 (USD MILLION) 201.
TABLE 244 REST OF EUROPE: MEMBRANE CHROMATOGRAPHY MARKET, BY END USER, 2023–2031 (USD MILLION) 201.
TABLE 245 ASIA PACIFIC: MEMBRANE CHROMATOGRAPHY MARKET, BY COUNTRY, 2023–2031 (USD MILLION) 203.
TABLE 246 ASIA PACIFIC: MEMBRANE CHROMATOGRAPHY MARKET, BY PRODUCT, 2023–2031 (USD MILLION) 203.
TABLE 247 ASIA PACIFIC: MEMBRANE CHROMATOGRAPHY MARKET, BY TECHNIQUE, 2023–2031 (USD MILLION) 204.
TABLE 248 ASIA PACIFIC: ION EXCHANGE MEMBRANE CHROMATOGRAPHY MARKET, BY TYPE, 2023–2031 (USD MILLION) 204.
TABLE 249 ASIA PACIFIC: MEMBRANE CHROMATOGRAPHY MARKET, BY OPERATION MODE, 2023–2031 (USD MILLION) 204.
TABLE 250 ASIA PACIFIC: MEMBRANE CHROMATOGRAPHY MARKET, BY MEMBRANE MATERIAL,.
2023–2031 (USD MILLION) 205.
TABLE 251 ASIA PACIFIC: MEMBRANE CHROMATOGRAPHY MARKET, BY END USER, 2023–2031 (USD MILLION) 205.
TABLE 252 CHINA: MEMBRANE CHROMATOGRAPHY MARKET, BY PRODUCT, 2023–2031 (USD MILLION) 206.
TABLE 253 CHINA: MEMBRANE CHROMATOGRAPHY MARKET, BY TECHNIQUE, 2023–2031 (USD MILLION) 206.
TABLE 254 CHINA: ION EXCHANGE MEMBRANE CHROMATOGRAPHY MARKET, BY TYPE, 2023–2031 (USD MILLION) 206.
TABLE 255 CHINA: MEMBRANE CHROMATOGRAPHY MARKET, BY OPERATION MODE, 2023–2031 (USD MILLION) 207.
TABLE 256 CHINA: MEMBRANE CHROMATOGRAPHY MARKET, BY MEMBRANE MATERIAL, 2023–2031 (USD MILLION) 207.
TABLE 257 CHINA: MEMBRANE CHROMATOGRAPHY MARKET, BY END USER, 2023–2031 (USD MILLION) 207.
TABLE 258 JAPAN: MEMBRANE CHROMATOGRAPHY MARKET, BY PRODUCT, 2023–2031 (USD MILLION) 208.
TABLE 259 JAPAN: MEMBRANE CHROMATOGRAPHY MARKET, BY TECHNIQUE, 2023–2031 (USD MILLION) 208.
TABLE 260 JAPAN: ION EXCHANGE MEMBRANE CHROMATOGRAPHY MARKET, BY TYPE, 2023–2031 (USD MILLION) 209.
TABLE 261 JAPAN: MEMBRANE CHROMATOGRAPHY MARKET, BY OPERATION MODE, 2023–2031 (USD MILLION) 209.
TABLE 262 JAPAN: MEMBRANE CHROMATOGRAPHY MARKET, BY MEMBRANE MATERIAL, 2023–2031 (USD MILLION) 210.
TABLE 263 JAPAN: MEMBRANE CHROMATOGRAPHY MARKET, BY END USER, 2023–2031 (USD MILLION) 210.
TABLE 264 INDIA: MEMBRANE CHROMATOGRAPHY MARKET, BY PRODUCT, 2023–2031 (USD MILLION) 211.
TABLE 265 INDIA: MEMBRANE CHROMATOGRAPHY MARKET, BY TECHNIQUE, 2023–2031 (USD MILLION) 211.
TABLE 266 INDIA: ION EXCHANGE MEMBRANE CHROMATOGRAPHY MARKET, BY TYPE, 2023–2031 (USD MILLION) 211.
TABLE 267 INDIA: MEMBRANE CHROMATOGRAPHY MARKET, BY OPERATION MODE, 2023–2031 (USD MILLION) 212.
TABLE 268 INDIA: MEMBRANE CHROMATOGRAPHY MARKET, BY MEMBRANE MATERIAL, 2023–2031 (USD MILLION) 212.
TABLE 269 INDIA: MEMBRANE CHROMATOGRAPHY MARKET, BY END USER, 2023–2031 (USD MILLION) 212.
TABLE 270 SOUTH KOREA: MEMBRANE CHROMATOGRAPHY MARKET, BY PRODUCT, 2023–2031 (USD MILLION) 213.
TABLE 271 SOUTH KOREA: MEMBRANE CHROMATOGRAPHY MARKET, BY TECHNIQUE, 2023–2031 (USD MILLION) 213.
TABLE 272 SOUTH KOREA: ION EXCHANGE MEMBRANE CHROMATOGRAPHY MARKET, BY TYPE,.
2023–2031 (USD MILLION) 214.
TABLE 273 SOUTH KOREA: MEMBRANE CHROMATOGRAPHY MARKET, BY OPERATION MODE, 2023–2031 (USD MILLION) 214.
TABLE 274 SOUTH KOREA: MEMBRANE CHROMATOGRAPHY MARKET, BY MEMBRANE MATERIAL,.
2023–2031 (USD MILLION) 214.
TABLE 275 SOUTH KOREA: MEMBRANE CHROMATOGRAPHY MARKET, BY END USER, 2023–2031 (USD MILLION) 215.
TABLE 276 AUSTRALIA: MEMBRANE CHROMATOGRAPHY MARKET, BY PRODUCT, 2023–2031 (USD MILLION) 215.
TABLE 277 AUSTRALIA: MEMBRANE CHROMATOGRAPHY MARKET, BY TECHNIQUE, 2023–2031 (USD MILLION) 216.
TABLE 278 AUSTRALIA: ION EXCHANGE MEMBRANE CHROMATOGRAPHY MARKET, BY TYPE, 2023–2031 (USD MILLION) 216.
TABLE 279 AUSTRALIA: MEMBRANE CHROMATOGRAPHY MARKET, BY OPERATION MODE, 2023–2031 (USD MILLION) 216.
TABLE 280 AUSTRALIA: MEMBRANE CHROMATOGRAPHY MARKET, BY MEMBRANE MATERIAL,.
2023–2031 (USD MILLION) 217.
TABLE 281 AUSTRALIA: MEMBRANE CHROMATOGRAPHY MARKET, BY END USER, 2023–2031 (USD MILLION) 217.
TABLE 282 REST OF ASIA PACIFIC: MEMBRANE CHROMATOGRAPHY MARKET, BY PRODUCT, 2023–2031 (USD MILLION) 218.
TABLE 283 REST OF ASIA PACIFIC: MEMBRANE CHROMATOGRAPHY MARKET, BY TECHNIQUE, 2023–2031 (USD MILLION) 218.

 

ページTOPに戻る


 

Summary

The global membrane chromatography market is estimated to grow from USD 0.37 billion in 2026 to USD 0.63 billion by 2031, at a CAGR of 11.3% from 2026 to 2031. The market is projected to grow steadily over the forecast period, driven by rising biopharmaceutical production, increasing biopharmaceutical R&D, and the operational benefits of membrane chromatography over conventional chromatography techniques. Growth is further supported by increasing regulatory scrutiny on cleaning validation of downstream purification processes, expanded applications and diversification, and the widespread adoption of single-use technologies. Additional opportunities are emerging from the expansion of membrane chromatography from polishing into capture and bind-and-elute applications, growing integration with intensified and continuous bioprocessing, and increasing biomanufacturing capacity in emerging markets.

The polyethersulfone (PES) segment accounted for the largest share, by membrane material, in 2025.
Based on membrane material, the membrane chromatography market is segmented into polyethersulfone (PES), cellulose, hydrogel, and other membrane materials. In 2025, polyethersulfone accounted for the largest share of the membrane chromatography market, driven by its high chemical resistance, mechanical strength, permeability, and compatibility with a broad range of bioprocessing conditions. PES membranes are widely used in membrane-based separation and purification workflows owing to their process stability, scalability, and suitability for high-throughput applications. Demand is further supported by the growing adoption of single-use downstream processing and membrane-based purification across pharmaceutical & biopharmaceutical companies, CROs & CDMOs, and academic & research institutes. The material’s established use in filtration and purification, coupled with its compatibility with diverse process conditions, continues to support the segment’s global leadership.

Flow-through membrane chromatography accounted for the largest share of the membrane chromatography market, by operation mode, in 2025.
Based on operation mode, the membrane chromatography market is segmented into flow-through membrane chromatography and bind-elute membrane chromatography. Flow-through membrane chromatography accounted for the largest market share in 2025, driven by its widespread use in high-throughput impurity removal and polishing across biopharmaceutical downstream processing.

Flow-through membrane chromatography offers rapid processing, high flow rates, low pressure drop, and compatibility with single-use workflows. It is widely used to remove host cell proteins, DNA, viruses, endotoxins, and other process-related impurities while allowing the target biomolecule to pass through. Its suitability for process intensification, reduced processing time, and scalable downstream purification across pharmaceutical & biopharmaceutical companies and CROs & CDMOs continues to support the segment’s leading position.

Asia Pacific is expected to register the highest CAGR in the membrane chromatography market from 2026 to 2031.
The membrane chromatography market is segmented by region into North America, Europe, Asia Pacific, Latin America, the Middle East, and Africa. Asia Pacific is estimated to grow at the highest CAGR during the forecast period, driven by expanding biopharmaceutical manufacturing, rising biotechnology R&D, growing CDMO activity, and increasing investments in biologics and advanced therapy production. Growth is further supported by increasing adoption of single-use downstream processing, high-throughput purification technologies, and advanced membrane chromatography solutions across China, India, Japan, South Korea, and Australia. Expanding regional manufacturing capacity and strengthening bioprocessing infrastructure continue to enhance membrane chromatography capabilities across the region.

The primary interviews conducted for this report can be categorized as follows:
- By Respondent: Supply Side (80%) and Demand Side (20%)
- By Designation: Managers (45%), CXOs & Directors (30%), and Executives (25%)
- By Region: North America (40%), Europe (25%), Asia Pacific (25%), Latin America (5%), and the Middle East & Africa (5%)

Danaher Corporation (US), Sartorius AG (Germany), Merck KGaA (Germany), Thermo Fisher Scientific Inc. (US), Agilent Technologies, Inc. (US), Donaldson Company, Inc. (US), GVS S.p.A. (Italy), i3 Membrane GmbH (Germany), Restek Corporation (US), Shimadzu Corporation (Japan), W. L. Gore & Associates, Inc. (US), MACHEREY-NAGEL GmbH & Co. KG (Germany), MICROSOLV (US), Cobetter (China), Porvair Sciences Ltd. (UK), Nupore Filtration Systems (India), Sterlitech Corporation (US), Microlab Scientific Co., Ltd. (China), Nantong FilterBio Membrane Co., Ltd. (China), Hahnemühle FineArt GmbH (Germany), Biocomma Limited (China), Astrea Bioseparations (UK), Bio-Rad Laboratories, Inc. (US), Membrane Solutions (China), and GL Sciences Inc. (Japan) are some of the key companies offering membrane chromatography products and solutions.

Research Coverage
This research report categorizes the membrane chromatography market by product (capsules, cassettes, and cartridges; syringe filters; filter plates; spin columns; membrane discs & sheets; and other consumables & accessories), technique [ion exchange membrane chromatography (anion exchange membrane chromatography and cation exchange membrane chromatography), affinity membrane chromatography, and hydrophobic interaction membrane chromatography], operation mode (flow-through membrane chromatography and bind-elute membrane chromatography), membrane material (polyethersulfone, cellulose, hydrogel, and other membrane materials), end user (pharmaceutical & biopharmaceutical companies, CROs & CDMOs, and academic & research institutes), and region (North America, Europe, Asia Pacific, Latin America, the Middle East, and Africa).

The report covers key growth drivers, along with challenges, opportunities, and restraints in the membrane chromatography market. A comprehensive analysis of major industry players provides insights into their business overviews, product & service portfolios, and key strategies, including collaborations, partnerships, expansions, agreements, acquisitions, and recent developments. The report also includes a competitive analysis of leading companies and emerging startups in the membrane chromatography market.

Key Benefits of Buying the Report
This report offers a comprehensive overview of the membrane chromatography market. It assesses market size and future growth opportunities across segments. The report also features an in-depth competitive analysis of the major market players, including their company profiles, recent developments, and key market strategies.

The report provides insights on the following pointers:
- Analysis of key drivers (benefits offered by membrane chromatography over conventional chromatography techniques, increasing biopharmaceutical R&D, increasing regulatory scrutiny on cleaning validation of downstream purification processes, increasing production of biopharmaceuticals, expanded applications and diversification, and shift toward single-use technologies), restraints (limited use of membrane chromatography products in large-scale manufacturing and restrictions on the use of fluorinated substances), opportunities (emerging markets, integration with continuous bioprocessing, and expansion of membrane chromatography from polishing to capture and bind-and-elute applications), and challenges (presence of alternative techniques to chromatography and technical limitations associated with membrane chromatography) influencing the growth of the membrane chromatography market.
- Product Development/Innovation: Detailed insights on newly launched products of the membrane chromatography market.
- Market Development: Comprehensive information about lucrative markets; the report analyzes the market across varied regions.
- Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the membrane chromatography market.
- Competitive Assessment: In-depth assessment of market shares, growth strategies, and product offerings of leading players such as Danaher Corporation (US), Sartorius AG (Germany), Merck KGaA (Germany), Thermo Fisher Scientific Inc. (US), i3 Membrane GmbH (Germany), Agilent Technologies, Inc. (US), Donaldson Company, Inc. (US), GVS S.p.A. (Italy), Restek Corporation (US), Shimadzu Corporation (Japan), W. L. Gore & Associates, Inc. (US), MACHEREY-NAGEL GmbH & Co. KG (Germany), MICROSOLV (US), Cobetter (China), Porvair Sciences Ltd. (UK), Nupore Filtration Systems (India), Sterlitech Corporation (US), Microlab Scientific Co., Ltd. (China), Nantong FilterBio Membrane Co., Ltd. (China), Hahnemühle FineArt GmbH (Germany), Biocomma Limited (China), Astrea Bioseparations (UK), Bio-Rad Laboratories, Inc. (US), Membrane Solutions (China), and GL Sciences Inc. (Japan).

The report also helps stakeholders understand trends in the membrane chromatography market and provides information on key drivers, restraints, challenges, and opportunities. A detailed analysis of the key industry players has been conducted to offer insights into their strategies, product & service launches, acquisitions, partnerships, collaborations, recent activities, investments, funding, brand/product comparisons, vendor evaluations, and financial metrics of the membrane chromatography sector.



ページTOPに戻る


Table of Contents

1 INTRODUCTION 32
1.1 STUDY OBJECTIVES 32
1.2 MARKET DEFINITION 32
1.3 STUDY SCOPE 33
1.3.1 MARKET SEGMENTATION AND REGIONS COVERED 33
1.3.2 INCLUSIONS AND EXCLUSIONS 34
1.3.3 YEARS CONSIDERED 34
1.3.4 CURRENCY CONSIDERED 35
1.3.5 UNIT CONSIDERED 35
1.4 STAKEHOLDERS 35
1.5 SUMMARY OF CHANGES 35

2 EXECUTIVE SUMMARY 37
2.1 MARKET HIGHLIGHTS & KEY INSIGHTS 37
2.2 KEY MARKET PARTICIPANTS: MAPPING OF STRATEGIC DEVELOPMENTS 39
2.3 DISRUPTIVE TRENDS IN MEMBRANE CHROMATOGRAPHY MARKET 40
2.4 HIGH-GROWTH SEGMENTS 41
2.5 REGIONAL SNAPSHOT: MARKET SIZE, GROWTH RATE, AND FORECAST 42

3 PREMIUM INSIGHTS 44
3.1 MEMBRANE CHROMATOGRAPHY MARKET OVERVIEW 44
3.2 NORTH AMERICA: MEMBRANE CHROMATOGRAPHY MARKET, OPERATION MODE AND COUNTRY 45
3.3 MEMBRANE CHROMATOGRAPHY MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 46
3.4 MEMBRANE CHROMATOGRAPHY MARKET SHARE, BY END USER 46

4 MARKET OVERVIEW 47
4.1 INTRODUCTION 47
4.2 MARKET DYNAMICS 47
4.2.1 DRIVERS 48
4.2.1.1 Benefits offered by membrane chromatography over conventional chromatography techniques 48
4.2.1.2 Increasing biopharmaceutical R&D 50
4.2.1.3 Increasing regulatory scrutiny on cleaning validation of downstream purification processes 51
4.2.1.4 Increasing production of biopharmaceuticals 51
4.2.1.5 Expanded applications and diversification 52
4.2.1.6 Shift toward single-use technologies 53
4.2.2 RESTRAINTS 54
4.2.2.1 Limited use of membrane chromatography products in large-scale manufacturing 54
4.2.2.2 Restrictions on use of fluorinated substances 55
4.2.3 OPPORTUNITIES 55
4.2.3.1 Emerging markets 55
4.2.3.2 Integration with continuous bioprocessing 56
4.2.3.3 Expansion of membrane chromatography from polishing to capture and bind-and-elute applications 56
4.2.4 CHALLENGES 57
4.2.4.1 Presence of alternative techniques to chromatography 57
4.2.4.2 Technical limitations associated with membrane chromatography 58
4.3 UNMET NEEDS & WHITE SPACES 58
4.4 INTERCONNECTED MARKETS & CROSS-SECTOR OPPORTUNITIES 59
4.5 STRATEGIC MOVES BY TIER-1/2/3 PLAYERS 59

5 INDUSTRY TRENDS 60
5.1 PORTER’S FIVE FORCES ANALYSIS 60
5.1.1 BARGAINING POWER OF SUPPLIERS 61
5.1.2 BARGAINING POWER OF BUYERS 61
5.1.3 THREAT OF NEW ENTRANTS 61
5.1.4 THREAT OF SUBSTITUTES 61
5.1.5 INTENSITY OF COMPETITIVE RIVALRY 62
5.2 MACROECONOMIC OUTLOOK 62
5.2.1 INTRODUCTION 62
5.2.2 GDP TRENDS & FORECAST 62
5.2.3 TRENDS IN GLOBAL MEMBRANE CHROMATOGRAPHY INDUSTRY 63
5.3 VALUE CHAIN ANALYSIS 64
5.4 ECOSYSTEM ANALYSIS 65
5.5 PRICING ANALYSIS 67
5.5.1 AVERAGE SELLING PRICE TREND OF MEMBRANE CHROMATOGRAPHY PRODUCTS,
BY KEY PLAYER 68
5.5.2 AVERAGE SELLING PRICE TREND, BY REGION 69
5.6 TRADE DATA 70
5.6.1 IMPORT SCENARIO (HS CODE 842129) 70
5.6.2 EXPORT SCENARIO (HS CODE 842129) 72
5.7 KEY CONFERENCES & EVENTS, 2026–2027 73
5.8 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 74
5.9 INVESTMENT AND FUNDING SCENARIO 75
5.9.1 VC/PRIVATE EQUITY INVESTMENT TRENDS & STARTUP LANDSCAPE 75
5.10 IMPACT OF 2025 US TARIFFS—MEMBRANE CHROMATOGRAPHY MARKET 76
5.10.1 INTRODUCTION 76
5.10.2 KEY TARIFF RATES 76
5.10.3 PRICE IMPACT ANALYSIS 77
5.10.4 IMPACT ON COUNTRIES/REGIONS 78
5.10.4.1 US 78
5.10.4.2 Europe 78
5.10.4.3 Asia Pacific 78
5.10.5 IMPACT ON END-USE INDUSTRIES 79
5.10.5.1 Pharmaceutical & biotech companies 79
5.10.5.2 CROs and CDMOs 79
5.10.5.3 Academic & research institutes 80

6 TECHNOLOGICAL ADVANCEMENTS, AI-DRIVEN IMPACT, PATENTS, AND INNOVATIONS 81
6.1 TECHNOLOGY ANALYSIS 81
6.1.1 KEY EMERGING TECHNOLOGIES 81
6.1.1.1 Single-use technology 81
6.1.1.2 Continuous membrane chromatography 83
6.1.1.3 Nanofiber-based membrane chromatography 83
6.1.2 COMPLEMENTARY TECHNOLOGIES 83
6.1.2.1 High-throughput screening 83
6.1.2.2 Mass spectrometry 83
6.1.3 ADJACENT TECHNOLOGIES 84
6.1.3.1 Monolith chromatography 84
6.1.3.2 Tangential flow filtration 84
6.2 TECHNOLOGY/PRODUCT ROADMAP 85
6.3 PATENT ANALYSIS 85
6.3.1 TOP APPLICANTS/OWNERS (COMPANIES) FOR MEMBRANE CHROMATOGRAPHY PATENTS 86
6.4 FUTURE APPLICATIONS 88
6.5 IMPACT OF AI/GENAI ON MEMBRANE CHROMATOGRAPHY MARKET 89
6.5.1 BEST PRACTICES IN MEMBRANE CHROMATOGRAPHY WORKFLOW 90
6.5.2 CASE STUDIES OF AI IMPLEMENTATION 91
6.5.3 INTERCONNECTED ADJACENT ECOSYSTEMS & IMPACT ON MARKET PLAYERS 91
6.5.4 CLIENTS’ READINESS TO ADOPT GENERATIVE AI IN MEMBRANE CHROMATOGRAPHY MARKET 91

7 REGULATORY LANDSCAPE & SUSTAINABILITY INITIATIVES 93
7.1 REGIONAL REGULATIONS & COMPLIANCE 93
7.1.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 93
7.1.2 REGULATORY FRAMEWORK 96
7.1.2.1 North America 96
7.1.2.2 Europe 97
7.1.2.3 Asia Pacific 97
7.1.2.4 Latin America 98
7.1.2.5 Middle East & Africa 98
7.1.3 INDUSTRY STANDARDS 98
7.2 SUSTAINABILITY INITIATIVES 99
7.3 IMPACT OF REGULATORY POLICIES ON SUSTAINABILITY INITIATIVES 99
7.4 CERTIFICATIONS, LABELING, AND ECO-STANDARDS 99

8 CUSTOMER LANDSCAPE & BUYER BEHAVIOR 100
8.1 DECISION-MAKING PROCESS 100
8.2 BUYER STAKEHOLDERS & BUYING EVALUATION CRITERIA 100
8.2.1 KEY STAKEHOLDERS IN BUYING PROCESS 100
8.2.2 KEY BUYING CRITERIA, BY END USER 101
8.3 ADOPTION BARRIERS & INTERNAL CHALLENGES 103
8.4 UNMET NEEDS FROM VARIOUS END-USE INDUSTRIES 103
8.5 MARKET PROFITABILITY 103

9 MEMBRANE CHROMATOGRAPHY MARKET, BY PRODUCT 104
9.1 INTRODUCTION 105
9.2 CAPSULES, CASSETTES, AND CARTRIDGES 106
9.2.1 INCREASING ADOPTION IN HIGH-THROUGHPUT, SINGLE-USE, AND
COMMERCIAL-SCALE PURIFICATION TO DRIVE MARKET GROWTH 106
9.3 SYRINGE FILTERS 109
9.3.1 RISING SAMPLE PREPARATION AND ANALYTICAL TESTING VOLUMES TO SUSTAIN DEMAND 109
9.4 FILTER PLATES 111
9.4.1 INCREASING HIGH-THROUGHPUT SCREENING AND PROCESS DEVELOPMENT TO SUPPORT RAPID ADOPTION 111
9.5 SPIN COLUMNS 114
9.5.1 CONVENIENT PROCESSING OF MULTIPLE SMALL-SCALE SAMPLES TO
PROPEL MARKET GROWTH 114
9.6 MEMBRANE DISCS & SHEETS 117
9.6.1 USED AS SEPARATION TOOLS IN A VARIETY OF VIRAL AND PROTEIN PURIFICATION APPLICATIONS 117
9.7 OTHER CONSUMABLES & ACCESSORIES 120

10 MEMBRANE CHROMATOGRAPHY MARKET, BY TECHNIQUE 123
10.1 INTRODUCTION 124
10.2 ION EXCHANGE MEMBRANE CHROMATOGRAPHY 124
10.2.1 ANION EXCHANGE MEMBRANE CHROMATOGRAPHY 128
10.2.1.1 Increasing adoption for monoclonal antibody purification to drive growth 128
10.2.2 CATION EXCHANGE MEMBRANE CHROMATOGRAPHY 131
10.2.2.1 Increasing demand for advanced chromatographic techniques for biologics production to support market growth 131
10.3 AFFINITY MEMBRANE CHROMATOGRAPHY 134
10.3.1 EXPANSION FROM POLISHING TO HIGH-VALUE CAPTURE APPLICATIONS TO DRIVE FASTEST MARKET GROWTH 134
10.4 HYDROPHOBIC INTERACTION MEMBRANE CHROMATOGRAPHY 137
10.4.1 GROWING ADOPTION OF HIMC TECHNIQUE FOR BIOMOLECULE PURIFICATION TO PROPEL MARKET 137

11 MEMBRANE CHROMATOGRAPHY MARKET, BY OPERATION MODE 140
11.1 INTRODUCTION 141
11.2 FLOW-THROUGH MEMBRANE CHROMATOGRAPHY 141
11.2.1 INCREASING FOCUS ON DEVELOPMENT OF BIOLOGICS TO DRIVE MARKET 141
11.3 BIND-ELUTE MEMBRANE CHROMATOGRAPHY 144
11.3.1 INCREASING ADOPTION FOR BIOPHARMACEUTICAL MANUFACTURING
TO AID MARKET GROWTH 144

12 MEMBRANE CHROMATOGRAPHY MARKET, BY MEMBRANE MATERIAL 147
12.1 INTRODUCTION 148
12.2 POLYETHERSULFONE 148
12.2.1 INCREASING DEMAND FOR HIGH-QUALITY MEMBRANE MATERIALS TO DRIVE GROWTH 148
12.3 CELLULOSE 152
12.3.1 STRONG, LIGHTWEIGHT, AND BIODEGRADABLE—KEY FACTORS DRIVING ADOPTION 152
12.4 HYDROGEL 155
12.4.1 GROWING NEED TO REDUCE MEMBRANE FOULING TO BOOST MARKET GROWTH 155
12.5 OTHER MEMBRANE MATERIALS 158

13 MEMBRANE CHROMATOGRAPHY MARKET, BY END USER 162
13.1 INTRODUCTION 163
13.2 PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES 163
13.2.1 LARGE-SCALE BIOLOGICS MANUFACTURING AND EXPANDING ADVANCED-THERAPY PIPELINES TO SUSTAIN SEGMENT LEADERSHIP 163
13.3 CROS & CDMOS 166
13.3.1 RISING OUTSOURCING OF R&D SERVICES BY PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES TO DRIVE MARKET 166
13.4 ACADEMIC & RESEARCH INSTITUTES 169
13.4.1 SURGE IN R&D ACTIVITIES FOR DEVELOPMENT OF BIOPHARMACEUTICALS
TO PROPEL MARKET 169

14 MEMBRANE CHROMATOGRAPHY MARKET, BY REGION 173
14.1 INTRODUCTION 174
14.2 NORTH AMERICA 174
14.2.1 US 178
14.2.1.1 Patent expiry of biopharmaceuticals to support market growth 178
14.2.2 CANADA 181
14.2.2.1 Growing investments for advancement of biomanufacturing capacity to propel market 181
14.3 EUROPE 184
14.3.1 GERMANY 187
14.3.1.1 Growing investments by key market players for advancement of biological drug manufacturing capabilities to drive market 187
14.3.2 UK 190
14.3.2.1 Booming biotechnology industry to support market growth 190
14.3.3 FRANCE 192
14.3.3.1 Increasing focus on advancement of bioproduction capacities to promote market growth 192
14.3.4 ITALY 195
14.3.4.1 Growing biotech industry and rising R&D activities to propel market 195
14.3.5 SPAIN 197
14.3.5.1 Increasing number of biotechnology companies to propel market 197
14.3.6 REST OF EUROPE 199
14.4 ASIA PACIFIC 202
14.4.1 CHINA 205
14.4.1.1 Growing focus on facility expansion to drive market 205
14.4.2 JAPAN 208
14.4.2.1 Growing government initiatives and increasing focus on facility expansion to propel market 208
14.4.3 INDIA 210
14.4.3.1 Growing number of biosimilar approvals to drive market 210
14.4.4 SOUTH KOREA 213
14.4.4.1 Growing strategic alliances for advancement of bioprocessing sector to support market growth 213
14.4.5 AUSTRALIA 215
14.4.5.1 Growing biopharmaceutical manufacturing industry to propel market 215
14.4.6 REST OF ASIA PACIFIC 217
14.5 LATIN AMERICA 220
14.5.1 BRAZIL 223
14.5.1.1 Rising demand for biopharmaceuticals to drive market 223
14.5.2 MEXICO 225
14.5.2.1 Increasing government support for biopharmaceutical production to support market growth 225
14.5.3 REST OF LATIN AMERICA 227
14.6 MIDDLE EAST 230
14.6.1 GCC COUNTRIES 232
14.6.1.1 Saudi Arabia 235
14.6.1.1.1 Increasing focus on advancements in healthcare sector to drive market 235
14.6.1.2 United Arab Emirates 237
14.6.1.2.1 Advancements in biopharmaceutical sector to propel market growth 237
14.6.1.3 Rest of GCC Countries 240
14.6.2 REST OF MIDDLE EAST 242
14.7 AFRICA 245
14.7.1 RISING FUNDING FOR DEVELOPMENT AND MANUFACTURING OF BIOPHARMACEUTICALS TO AID MARKET GROWTH 245

15 COMPETITIVE LANDSCAPE 248
15.1 OVERVIEW 248
15.2 KEY PLAYER STRATEGIES/RIGHT TO WIN 248
15.2.1 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN MEMBRANE CHROMATOGRAPHY MARKET 249
15.3 REVENUE ANALYSIS, 2021–2025 250
15.4 MARKET SHARE ANALYSIS 251
15.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2025 254
15.5.1 STARS 254
15.5.2 EMERGING LEADERS 254
15.5.3 PERVASIVE PLAYERS 254
15.5.4 PARTICIPANTS 254
15.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2025 256
15.5.5.1 Company footprint 256
15.5.5.2 Region footprint 256
15.5.5.3 Product footprint 257
15.5.5.4 Technique footprint 258
15.5.5.5 Membrane material footprint 259
15.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2025 260
15.6.1 PROGRESSIVE COMPANIES 260
15.6.2 RESPONSIVE COMPANIES 260
15.6.3 DYNAMIC COMPANIES 260
15.6.4 STARTING BLOCKS 260
15.6.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2025 262
15.6.5.1 Detailed list of key startups/SMEs 262
15.6.5.2 Competitive benchmarking of startups/SMEs 263
15.7 COMPANY VALUATION AND FINANCIAL METRICS 264
15.7.1 FINANCIAL METRICS 264
15.7.2 COMPANY VALUATION 264
15.8 BRAND/PRODUCT COMPARISON 265
15.9 COMPETITIVE SCENARIO 266
15.9.1 PRODUCT LAUNCHES 266
15.9.2 DEALS 267
15.9.3 EXPANSIONS 268

16 COMPANY PROFILES 269
16.1 INTRODUCTION 269
16.2 KEY PLAYERS 269
16.2.1 DANAHER CORPORATION 269
16.2.1.1 Business overview 269
16.2.1.2 Products offered 270
16.2.1.3 Recent developments 272
16.2.1.3.1 Expansions 272
16.2.1.3.2 Other developments 272
16.2.1.4 MnM view 273
16.2.1.4.1 Key strengths 273
16.2.1.4.2 Strategic choices 273
16.2.1.4.3 Weaknesses and competitive threats 273
16.2.2 SARTORIUS AG 274
16.2.2.1 Business overview 274
16.2.2.2 Products offered 275
16.2.2.3 Recent developments 278
16.2.2.3.1 Product launches 278
16.2.2.3.2 Deals 278
16.2.2.4 MnM view 278
16.2.2.4.1 Key strengths 278
16.2.2.4.2 Strategic choices 278
16.2.2.4.3 Weaknesses and competitive threats 279
16.2.3 MERCK KGAA 280
16.2.3.1 Business overview 280
16.2.3.2 Products offered 281
16.2.3.3 Recent developments 282
16.2.3.3.1 Product launches 282
16.2.3.4 MnM view 282
16.2.3.4.1 Key strengths 282
16.2.3.4.2 Strategic choices 282
16.2.3.4.3 Weaknesses and competitive threats 282
16.2.4 THERMO FISHER SCIENTIFIC INC. 283
16.2.4.1 Business overview 283
16.2.4.2 Products offered 284
16.2.4.3 Recent developments 285
16.2.4.3.1 Deals 285
16.2.4.3.2 Expansions 285
16.2.4.4 MnM view 286
16.2.4.4.1 Key strengths 286
16.2.4.4.2 Strategic choices 286
16.2.4.4.3 Weaknesses and competitive threats 286
16.2.5 AGILENT TECHNOLOGIES, INC. 287
16.2.5.1 Business overview 287
16.2.5.2 Products offered 289
16.2.5.3 Recent developments 289
16.2.5.3.1 Expansions 289
16.2.6 DONALDSON COMPANY, INC. 290
16.2.6.1 Business overview 290
16.2.6.2 Products offered 291
16.2.6.3 Recent developments 292
16.2.6.3.1 Product launches 292
16.2.6.3.2 Expansions 292
16.2.7 SHIMADZU CORPORATION 293
16.2.7.1 Business overview 293
16.2.7.2 Products offered 294
16.2.8 GVS S.P.A. 295
16.2.8.1 Business overview 295
16.2.8.2 Products offered 297
16.2.9 I3 MEMBRANE GMBH 298
16.2.9.1 Business overview 298
16.2.9.2 Products offered 298
16.2.9.3 Recent developments 299
16.2.9.3.1 Product launches 299
16.2.10 RESTEK CORPORATION 300
16.2.10.1 Business overview 300
16.2.10.2 Products offered 300
16.2.11 W. L. GORE & ASSOCIATES, INC. 301
16.2.11.1 Business overview 301
16.2.11.2 Products offered 301
16.2.11.3 Recent developments 302
16.2.11.3.1 Product launches 302
16.2.11.3.2 Deals 302
16.2.12 MACHEREY-NAGEL GMBH & CO. KG 303
16.2.12.1 Business overview 303
16.2.12.2 Products offered 303
16.2.12.3 Recent developments 304
16.2.12.3.1 Product launches 304
16.2.12.3.2 Deals 304
16.2.13 MICROSOLV 305
16.2.13.1 Business overview 305
16.2.13.2 Products offered 305
16.3 OTHER PLAYERS 306
16.3.1 COBETTER 306
16.3.2 PORVAIR SCIENCES LTD. 306
16.3.3 NUPORE FILTRATION SYSTEMS 307
16.3.4 STERLITECH CORPORATION 307
16.3.5 MICROLAB SCIENTIFIC CO., LTD. 308
16.3.6 NANTONG FILTERBIO MEMBRANE CO., LTD. 308
16.3.7 HAHNEMÜHLE FINEART GMBH 309
16.3.8 BIOCOMMA LIMITED 309
16.3.9 ASTREA BIOSEPARATIONS 310
16.3.10 BIO-RAD LABORATORIES, INC. 310
16.3.11 MEMBRANE SOLUTIONS 311
16.3.12 GL SCIENCES INC. 311

17 RESEARCH METHODOLOGY 312
17.1 RESEARCH DATA 312
17.1.1 SECONDARY DATA 313
17.1.1.1 Key secondary sources 313
17.1.1.2 Key data from secondary research 313
17.1.2 PRIMARY DATA 314
17.1.2.1 Key primary participants 314
17.1.2.2 Breakdown of primary interviews 314
17.1.2.3 Key data from primary sources 314
17.2 MARKET SIZE ESTIMATION 315
17.2.1 GLOBAL MEMBRANE CHROMATOGRAPHY MARKET ESTIMATION, 2025 315
17.2.1.1 Approach 1: Company revenue analysis-based estimation (bottom-up) 315
17.2.1.2 Approach 2: Primary research 317
17.2.1.2.1 Key industry insights 317
17.2.1.3 Approach 3: MnM repository analysis 317
17.2.2 SEGMENTAL MARKET SIZE ESTIMATION, 2025 318
17.3 MARKET GROWTH RATE PROJECTIONS 319
17.4 DATA TRIANGULATION 321
17.5 RESEARCH ASSUMPTIONS 322
17.6 RESEARCH LIMITATIONS AND RISK ASSESSMENT 323

18 APPENDIX 324
18.1 DISCUSSION GUIDE 324
18.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 327
18.3 CUSTOMIZATION OPTIONS 329
18.4 RELATED REPORTS 329
18.5 AUTHOR DETAILS 330

ページTOPに戻る



List of Tables/Graphs

FIGURE 1 MEMBRANE CHROMATOGRAPHY MARKET SEGMENTATION 33.
FIGURE 2 MEMBRANE CHROMATOGRAPHY MARKET: YEARS CONSIDERED 34.
FIGURE 3 MARKET SCENARIO 38.
FIGURE 4 GLOBAL MEMBRANE CHROMATOGRAPHY MARKET, 2024–2031 38.
FIGURE 5 MAJOR STRATEGIES ADOPTED BY KEY PLAYERS IN MEMBRANE CHROMATOGRAPHY MARKET, 2023–2026 39.
FIGURE 6 DISRUPTIONS INFLUENCING GROWTH OF MEMBRANE CHROMATOGRAPHY MARKET 40.
FIGURE 7 HIGH-GROWTH SEGMENTS IN MEMBRANE CHROMATOGRAPHY MARKET, 2026–2031 41.
FIGURE 8 ASIA PACIFIC TO REGISTER HIGHEST CAGR IN MEMBRANE CHROMATOGRAPHY MARKET, IN TERMS OF VALUE, DURING FORECAST PERIOD 42.
FIGURE 9 RISING BIOPHARMACEUTICAL PRODUCTION AND GROWING DEMAND FOR FLEXIBLE, HIGH-THROUGHPUT DOWNSTREAM PURIFICATION TO SUPPORT MARKET EXPANSION 44.
FIGURE 10 FLOW-THROUGH MEMBRANE CHROMATOGRAPHY AND US ACCOUNTED FOR LARGEST SHARES OF MEMBRANE CHROMATOGRAPHY MARKET IN NORTH AMERICA IN 2025 45.
FIGURE 11 ASIA PACIFIC LIKELY TO BE FASTEST-GROWING MARKET IN GLOBAL MEMBRANE CHROMATOGRAPHY MARKET DURING FORECAST PERIOD 46.
FIGURE 12 PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES TO DOMINATE MARKET DURING FORECAST PERIOD 46.
FIGURE 13 MEMBRANE CHROMATOGRAPHY MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 47.
FIGURE 14 CLINICAL TRIAL OVERVIEW OF GENE THERAPY PRODUCTS, Q4 2025 53.
FIGURE 15 MEMBRANE CHROMATOGRAPHY MARKET: PORTER’S FIVE FORCES ANALYSIS 60.
FIGURE 16 GLOBAL GDP GROWTH, 2020–2030 63.
FIGURE 17 MEMBRANE CHROMATOGRAPHY MARKET: VALUE CHAIN ANALYSIS 64.
FIGURE 18 MEMBRANE CHROMATOGRAPHY MARKET ECOSYSTEM 66.
FIGURE 19 AVERAGE SELLING PRICE TREND OF MEMBRANE CHROMATOGRAPHY PRODUCTS, 2023–2025 (USD) 69.
FIGURE 20 AVERAGE SELLING PRICE OF MEMBRANE CHROMATOGRAPHY PRODUCTS, BY REGION, 2025 (USD) 70.
FIGURE 21 REVENUE SHIFT AND NEW REVENUE POCKETS FOR PLAYERS IN MEMBRANE CHROMATOGRAPHY MARKET 74.
FIGURE 22 TOP APPLICANTS/OWNERS (COMPANIES) FOR MEMBRANE CHROMATOGRAPHY PATENTS, 2015–2025 86.
FIGURE 23 IMPACT OF AI/GENAI ON MEMBRANE CHROMATOGRAPHY MARKET 90.
FIGURE 24 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF MEMBRANE CHROMATOGRAPHY PRODUCTS 100.
FIGURE 25 KEY BUYING CRITERIA FOR MEMBRANE CHROMATOGRAPHY PRODUCTS, BY END USER 101.
FIGURE 26 NORTH AMERICA: MEMBRANE CHROMATOGRAPHY MARKET SNAPSHOT 175.
FIGURE 27 TOTAL BIOTECHNOLOGY FUNDING BY NATIONAL INSTITUTES OF HEALTH, 2013–2025 179.
FIGURE 28 ASIA PACIFIC: MEMBRANE CHROMATOGRAPHY MARKET SNAPSHOT 202.
FIGURE 29 REVENUE ANALYSIS OF KEY PLAYERS IN MEMBRANE CHROMATOGRAPHY MARKET,.
2021–2025 (USD MILLION) 251.
FIGURE 30 MARKET SHARE ANALYSIS OF KEY PLAYERS IN MEMBRANE CHROMATOGRAPHY MARKET, 2025 252.
FIGURE 31 MEMBRANE CHROMATOGRAPHY MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2025 255.
FIGURE 32 MEMBRANE CHROMATOGRAPHY MARKET: COMPANY FOOTPRINT, 2025 256.
FIGURE 33 MEMBRANE CHROMATOGRAPHY MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2025 261.
FIGURE 34 EV/EBITDA OF KEY VENDORS, 2026 264.
FIGURE 35 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY VENDORS, 2026 264.
FIGURE 36 MEMBRANE CHROMATOGRAPHY MARKET: BRAND/PRODUCT COMPARATIVE ANALYSIS 265.
FIGURE 37 DANAHER CORPORATION: COMPANY SNAPSHOT (2025) 270.
FIGURE 38 SARTORIUS AG: COMPANY SNAPSHOT (2025) 275.
FIGURE 39 MERCK KGAA: COMPANY SNAPSHOT (2025) 281.
FIGURE 40 THERMO FISHER SCIENTIFIC INC.: COMPANY SNAPSHOT (2025) 284.
FIGURE 41 AGILENT TECHNOLOGIES, INC.: COMPANY SNAPSHOT (2025) 288.
FIGURE 42 DONALDSON COMPANY, INC.: COMPANY SNAPSHOT (2025) 291.
FIGURE 43 SHIMADZU CORPORATION: COMPANY SNAPSHOT (2025) 294.
FIGURE 44 GVS S.P.A.: COMPANY SNAPSHOT (2025) 296.
FIGURE 45 MEMBRANE CHROMATOGRAPHY MARKET: RESEARCH DESIGN 312.
FIGURE 46 MEMBRANE CHROMATOGRAPHY MARKET: BREAKDOWN OF PRIMARIES 314.
FIGURE 47 GLOBAL MEMBRANE CHROMATOGRAPHY MARKET ESTIMATION, 2025 315.
FIGURE 48 MEMBRANE CHROMATOGRAPHY MARKET: COMPANY REVENUE ANALYSIS (BOTTOM-UP APPROACH) (2025) 316.
FIGURE 49 ILLUSTRATIVE EXAMPLE OF DANAHER CORPORATION: REVENUE ANALYSIS (2025) 316.
FIGURE 50 MEMBRANE CHROMATOGRAPHY MARKET: INSIGHTS FROM PRIMARIES 317.
FIGURE 51 SEGMENTAL MARKET SIZE ESTIMATION: TOP-DOWN APPROACH 318.
FIGURE 52 MEMBRANE CHROMATOGRAPHY MARKET: CAGR PROJECTIONS 320.
FIGURE 53 MEMBRANE CHROMATOGRAPHY MARKET: DATA TRIANGULATION 321.
TABLE 1 MEMBRANE CHROMATOGRAPHY MARKET: IMPACT ANALYSIS OF MARKET DYNAMICS 48.
TABLE 2 NATIONAL INSTITUTES OF HEALTH FUNDING FOR RESEARCH AREAS RELEVANT TO MEMBRANE CHROMATOGRAPHY, 2020–2025 (USD MILLION) 49.
TABLE 3 FUNDING INVESTMENTS IN MEMBRANE CHROMATOGRAPHY & DOWNSTREAM PURIFICATION, 2023–2026 49.
TABLE 4 KEY REGULATORY REQUIREMENTS FOR CLEANING VALIDATION OF DOWNSTREAM PURIFICATION PROCESSES 51.
TABLE 5 COMPARISON OF ALTERNATIVE DOWNSTREAM PURIFICATION TECHNIQUES 57.
TABLE 6 MEMBRANE CHROMATOGRAPHY MARKET: IMPACT OF PORTER’S FIVE FORCES 61.
TABLE 7 MEMBRANE CHROMATOGRAPHY MARKET: ROLE IN ECOSYSTEM 67.
TABLE 8 AVERAGE SELLING PRICE TREND OF MEMBRANE CHROMATOGRAPHY PRODUCTS, BY KEY PLAYER, 2023–2025 68.
TABLE 9 AVERAGE SELLING PRICE TREND OF MEMBRANE CHROMATOGRAPHY PRODUCTS, BY REGION,.
2023–2025 (USD) 69.
TABLE 10 IMPORT DATA FOR HS CODE 842129, 2021–2025 (USD THOUSAND) 70.
TABLE 11 IMPORT DATA FOR HS CODE 842129, 2021–2025 (TONS) 71.
TABLE 12 EXPORT DATA FOR HS CODE 842129, 2021–2025 (USD THOUSAND) 72.
TABLE 13 EXPORT DATA FOR HS CODE 842129, 2021–2025 (TONS) 72.
TABLE 14 MEMBRANE CHROMATOGRAPHY MARKET: KEY CONFERENCES & EVENTS, 2026–2027 73.
TABLE 15 US ADJUSTED RECIPROCAL TARIFF RATES 76.
TABLE 16 IMPACT ON END-USE APPLICATIONS 79.
TABLE 17 ADVANTAGES OF SINGLE-USE MEMBRANE CHROMATOGRAPHY OVER CONVENTIONAL PACKED-BED CHROMATOGRAPHY 82.
TABLE 18 ADVANTAGES AND DISADVANTAGES OF MONOLITH CHROMATOGRAPHY 84.
TABLE 19 MEMBRANE CHROMATOGRAPHY MARKET: INDICATIVE LIST OF PATENTS, 2026 87.
TABLE 20 CASE STUDIES OF AI IMPLEMENTATION IN MEMBRANE CHROMATOGRAPHY MARKET 91.
TABLE 21 CLIENTS’ READINESS TO ADOPT GENERATIVE AI IN MEMBRANE CHROMATOGRAPHY 92.
TABLE 22 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 93.
TABLE 23 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 94.
TABLE 24 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 95.
TABLE 25 REST OF THE WORLD: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 96.
TABLE 26 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS, BY PRODUCT 101.
TABLE 27 KEY BUYING CRITERIA, BY END USER 102.
TABLE 28 MEMBRANE CHROMATOGRAPHY MARKET, BY PRODUCT, 2023–2031 (USD MILLION) 105.
TABLE 29 MEMBRANE CHROMATOGRAPHY MARKET, BY PRODUCT, 2023–2031 (THOUSAND UNITS) 105.
TABLE 30 CAPSULES, CASSETTES, AND CARTRIDGES MARKET, BY REGION, 2023–2031 (USD MILLION) 106.
TABLE 31 NORTH AMERICA: CAPSULES, CASSETTES, AND CARTRIDGES MARKET, BY COUNTRY,.
2023–2031 (USD MILLION) 107.
TABLE 32 EUROPE: CAPSULES, CASSETTES, AND CARTRIDGES MARKET, BY COUNTRY, 2023–2031 (USD MILLION) 107.
TABLE 33 ASIA PACIFIC: CAPSULES, CASSETTES, AND CARTRIDGES MARKET, BY COUNTRY, 2023–2031 (USD MILLION) 107.
TABLE 34 LATIN AMERICA: CAPSULES, CASSETTES, AND CARTRIDGES MARKET, BY COUNTRY,.
2023–2031 (USD MILLION) 108.
TABLE 35 MIDDLE EAST: CAPSULES, CASSETTES, AND CARTRIDGES MARKET, BY REGION, 2023–2031 (USD MILLION) 108.
TABLE 36 GCC COUNTRIES: CAPSULES, CASSETTES, AND CARTRIDGES MARKET, BY COUNTRY,.
2023–2031 (USD MILLION) 108.
TABLE 37 SYRINGE FILTERS MARKET, BY REGION, 2023–2031 (USD MILLION) 109.
TABLE 38 NORTH AMERICA: SYRINGE FILTERS MARKET, BY COUNTRY, 2023–2031 (USD MILLION) 109.
TABLE 39 EUROPE: SYRINGE FILTERS MARKET, BY COUNTRY, 2023–2031 (USD MILLION) 110.
TABLE 40 ASIA PACIFIC: SYRINGE FILTERS MARKET, BY COUNTRY, 2023–2031 (USD MILLION) 110.
TABLE 41 LATIN AMERICA: SYRINGE FILTERS MARKET, BY COUNTRY, 2023–2031 (USD MILLION) 110.
TABLE 42 MIDDLE EAST: SYRINGE FILTERS MARKET, BY REGION, 2023–2031 (USD MILLION) 111.
TABLE 43 GCC COUNTRIES: SYRINGE FILTERS MARKET, BY COUNTRY, 2023–2031 (USD MILLION) 111.
TABLE 44 FILTER PLATES MARKET, BY REGION, 2023–2031 (USD MILLION) 112.
TABLE 45 NORTH AMERICA: FILTER PLATES MARKET, BY COUNTRY, 2023–2031 (USD MILLION) 112.
TABLE 46 EUROPE: FILTER PLATES MARKET, BY COUNTRY, 2023–2031 (USD MILLION) 112.
TABLE 47 ASIA PACIFIC: FILTER PLATES MARKET, BY COUNTRY, 2023–2031 (USD MILLION) 113.
TABLE 48 LATIN AMERICA: FILTER PLATES MARKET, BY COUNTRY, 2023–2031 (USD MILLION) 113.
TABLE 49 MIDDLE EAST: FILTER PLATES MARKET, BY REGION, 2023–2031 (USD MILLION) 113.
TABLE 50 GCC COUNTRIES: FILTER PLATES MARKET, BY COUNTRY, 2023–2031 (USD MILLION) 114.
TABLE 51 SPIN COLUMNS MARKET, BY REGION, 2023–2031 (USD MILLION) 114.
TABLE 52 NORTH AMERICA: SPIN COLUMNS MARKET, BY COUNTRY, 2023–2031 (USD MILLION) 115.
TABLE 53 EUROPE: SPIN COLUMNS MARKET, BY COUNTRY, 2023–2031 (USD MILLION) 115.
TABLE 54 ASIA PACIFIC: SPIN COLUMNS MARKET, BY COUNTRY, 2023–2031 (USD MILLION) 115.
TABLE 55 LATIN AMERICA: SPIN COLUMNS MARKET, BY COUNTRY, 2023–2031 (USD MILLION) 116.
TABLE 56 MIDDLE EAST: SPIN COLUMNS MARKET, BY REGION, 2023–2031 (USD MILLION) 116.
TABLE 57 GCC COUNTRIES: SPIN COLUMNS MARKET, BY COUNTRY, 2023–2031 (USD MILLION) 116.
TABLE 58 MEMBRANE DISCS & SHEETS MARKET, BY REGION, 2023–2031 (USD MILLION) 117.
TABLE 59 NORTH AMERICA: MEMBRANE DISCS & SHEETS MARKET, BY COUNTRY, 2023–2031 (USD MILLION) 118.
TABLE 60 EUROPE: MEMBRANE DISCS & SHEETS MARKET, BY COUNTRY, 2023–2031 (USD MILLION) 118.
TABLE 61 ASIA PACIFIC: MEMBRANE DISCS & SHEETS MARKET, BY COUNTRY, 2023–2031 (USD MILLION) 118.
TABLE 62 LATIN AMERICA: MEMBRANE DISCS & SHEETS MARKET, BY COUNTRY, 2023–2031 (USD MILLION) 119.
TABLE 63 MIDDLE EAST: MEMBRANE DISCS & SHEETS MARKET, BY REGION, 2023–2031 (USD MILLION) 119.
TABLE 64 GCC COUNTRIES: MEMBRANE DISCS & SHEETS MARKET, BY COUNTRY, 2023–2031 (USD MILLION) 119.
TABLE 65 OTHER CONSUMABLES & ACCESSORIES MARKET, BY REGION, 2023–2031 (USD MILLION) 120.
TABLE 66 NORTH AMERICA: OTHER CONSUMABLES & ACCESSORIES MARKET, BY COUNTRY,.
2023–2031 (USD MILLION) 120.
TABLE 67 EUROPE: OTHER CONSUMABLES & ACCESSORIES MARKET, BY COUNTRY, 2023–2031 (USD MILLION) 121.
TABLE 68 ASIA PACIFIC: OTHER CONSUMABLES & ACCESSORIES MARKET, BY COUNTRY, 2023–2031 (USD MILLION) 121.
TABLE 69 LATIN AMERICA: OTHER CONSUMABLES & ACCESSORIES MARKET, BY COUNTRY, 2023–2031 (USD MILLION) 122.
TABLE 70 MIDDLE EAST: OTHER CONSUMABLES & ACCESSORIES MARKET, BY REGION, 2023–2031 (USD MILLION) 122.
TABLE 71 GCC COUNTRIES: OTHER CONSUMABLES & ACCESSORIES MARKET, BY COUNTRY, 2023–2031 (USD MILLION) 122.
TABLE 72 MEMBRANE CHROMATOGRAPHY MARKET, BY TECHNIQUE, 2023–2031 (USD MILLION) 124.
TABLE 73 ION EXCHANGE MEMBRANE CHROMATOGRAPHY MARKET, BY TYPE, 2023–2031 (USD MILLION) 125.
TABLE 74 ION EXCHANGE MEMBRANE CHROMATOGRAPHY MARKET, BY REGION, 2023–2031 (USD MILLION) 125.
TABLE 75 NORTH AMERICA: ION EXCHANGE MEMBRANE CHROMATOGRAPHY MARKET, BY COUNTRY,.
2023–2031 (USD MILLION) 125.
TABLE 76 EUROPE: ION EXCHANGE MEMBRANE CHROMATOGRAPHY MARKET, BY COUNTRY,.
2023–2031 (USD MILLION) 126.
TABLE 77 ASIA PACIFIC: ION EXCHANGE MEMBRANE CHROMATOGRAPHY MARKET, BY COUNTRY,.
2023–2031 (USD MILLION) 126.
TABLE 78 LATIN AMERICA: ION EXCHANGE MEMBRANE CHROMATOGRAPHY MARKET, BY COUNTRY,.
2023–2031 (USD MILLION) 127.
TABLE 79 MIDDLE EAST: ION EXCHANGE MEMBRANE CHROMATOGRAPHY MARKET, BY REGION,.
2023–2031 (USD MILLION) 127.
TABLE 80 GCC COUNTRIES: ION EXCHANGE MEMBRANE CHROMATOGRAPHY MARKET, BY COUNTRY,.
2023–2031 (USD MILLION) 127.
TABLE 81 ANION EXCHANGE CHROMATOGRAPHY MEMBRANES: LIGAND FUNCTIONAL GROUPS 128.
TABLE 82 ANION EXCHANGE MEMBRANE CHROMATOGRAPHY MARKET, BY REGION, 2023–2031 (USD MILLION) 129.
TABLE 83 NORTH AMERICA: ANION EXCHANGE MEMBRANE CHROMATOGRAPHY MARKET, BY COUNTRY,.
2023–2031 (USD MILLION) 129.
TABLE 84 EUROPE: ANION EXCHANGE MEMBRANE CHROMATOGRAPHY MARKET, BY COUNTRY,.
2023–2031 (USD MILLION) 129.
TABLE 85 ASIA PACIFIC: ANION EXCHANGE MEMBRANE CHROMATOGRAPHY MARKET, BY COUNTRY,.
2023–2031 (USD MILLION) 130.
TABLE 86 LATIN AMERICA: ANION EXCHANGE MEMBRANE CHROMATOGRAPHY MARKET, BY COUNTRY,.
2023–2031 (USD MILLION) 130.
TABLE 87 MIDDLE EAST: ANION EXCHANGE MEMBRANE CHROMATOGRAPHY MARKET, BY REGION,.
2023–2031 (USD MILLION) 130.
TABLE 88 GCC COUNTRIES: ANION EXCHANGE MEMBRANE CHROMATOGRAPHY MARKET, BY COUNTRY,.
2023–2031 (USD MILLION) 131.
TABLE 89 CATION EXCHANGE CHROMATOGRAPHY MEMBRANES: LIGAND FUNCTIONAL GROUPS 131.
TABLE 90 CATION EXCHANGE MEMBRANE CHROMATOGRAPHY MARKET, BY REGION, 2023–2031 (USD MILLION) 132.
TABLE 91 NORTH AMERICA: CATION EXCHANGE MEMBRANE CHROMATOGRAPHY MARKET, BY COUNTRY,.
2023–2031 (USD MILLION) 132.
TABLE 92 EUROPE: CATION EXCHANGE MEMBRANE CHROMATOGRAPHY MARKET, BY COUNTRY,.
2023–2031 (USD MILLION) 132.
TABLE 93 ASIA PACIFIC: CATION EXCHANGE MEMBRANE CHROMATOGRAPHY MARKET, BY COUNTRY,.
2023–2031 (USD MILLION) 133.
TABLE 94 LATIN AMERICA: CATION EXCHANGE MEMBRANE CHROMATOGRAPHY MARKET, BY COUNTRY,.
2023–2031 (USD MILLION) 133.
TABLE 95 MIDDLE EAST: CATION EXCHANGE MEMBRANE CHROMATOGRAPHY MARKET, BY REGION,.
2023–2031 (USD MILLION) 133.
TABLE 96 GCC COUNTRIES: CATION EXCHANGE MEMBRANE CHROMATOGRAPHY MARKET, BY COUNTRY,.
2023–2031 (USD MILLION) 134.
TABLE 97 AFFINITY MEMBRANE CHROMATOGRAPHY MARKET, BY REGION, 2023–2031 (USD MILLION) 134.
TABLE 98 NORTH AMERICA: AFFINITY MEMBRANE CHROMATOGRAPHY MARKET, BY COUNTRY,.
2023–2031 (USD MILLION) 135.
TABLE 99 EUROPE: AFFINITY MEMBRANE CHROMATOGRAPHY MARKET, BY COUNTRY, 2023–2031 (USD MILLION) 135.
TABLE 100 ASIA PACIFIC: AFFINITY MEMBRANE CHROMATOGRAPHY MARKET, BY COUNTRY, 2023–2031 (USD MILLION) 135.
TABLE 101 LATIN AMERICA: AFFINITY MEMBRANE CHROMATOGRAPHY MARKET, BY COUNTRY,.
2023–2031 (USD MILLION) 136.
TABLE 102 MIDDLE EAST: AFFINITY MEMBRANE CHROMATOGRAPHY MARKET, BY REGION, 2023–2031 (USD MILLION) 136.
TABLE 103 GCC COUNTRIES: AFFINITY MEMBRANE CHROMATOGRAPHY MARKET, BY COUNTRY,.
2023–2031 (USD MILLION) 136.
TABLE 104 HYDROPHOBIC INTERACTION MEMBRANE CHROMATOGRAPHY MARKET, BY REGION,.
2023–2031 (USD MILLION) 137.
TABLE 105 NORTH AMERICA: HYDROPHOBIC INTERACTION MEMBRANE CHROMATOGRAPHY MARKET, BY COUNTRY,.
2023–2031 (USD MILLION) 138.
TABLE 106 EUROPE: HYDROPHOBIC INTERACTION MEMBRANE CHROMATOGRAPHY MARKET, BY COUNTRY,.
2023–2031 (USD MILLION) 138.
TABLE 107 ASIA PACIFIC: HYDROPHOBIC INTERACTION MEMBRANE CHROMATOGRAPHY MARKET, BY COUNTRY,.
2023–2031 (USD MILLION) 138.
TABLE 108 LATIN AMERICA: HYDROPHOBIC INTERACTION MEMBRANE CHROMATOGRAPHY MARKET, BY COUNTRY,.
2023–2031 (USD MILLION) 139.
TABLE 109 MIDDLE EAST: HYDROPHOBIC INTERACTION MEMBRANE CHROMATOGRAPHY MARKET, BY REGION,.
2023–2031 (USD MILLION) 139.
TABLE 110 GCC COUNTRIES: HYDROPHOBIC INTERACTION MEMBRANE CHROMATOGRAPHY MARKET, BY COUNTRY,.
2023–2031 (USD MILLION) 139.
TABLE 111 MEMBRANE CHROMATOGRAPHY MARKET, BY OPERATION MODE, 2023–2031 (USD MILLION) 141.
TABLE 112 FLOW-THROUGH MEMBRANE CHROMATOGRAPHY MARKET, BY REGION, 2023–2031 (USD MILLION) 142.
TABLE 113 NORTH AMERICA: FLOW-THROUGH MEMBRANE CHROMATOGRAPHY MARKET, BY COUNTRY,.
2023–2031 (USD MILLION) 142.
TABLE 114 EUROPE: FLOW-THROUGH MEMBRANE CHROMATOGRAPHY MARKET, BY COUNTRY,.
2023–2031 (USD MILLION) 142.
TABLE 115 ASIA PACIFIC: FLOW-THROUGH MEMBRANE CHROMATOGRAPHY MARKET, BY COUNTRY,.
2023–2031 (USD MILLION) 143.
TABLE 116 LATIN AMERICA: FLOW-THROUGH MEMBRANE CHROMATOGRAPHY MARKET, BY COUNTRY,.
2023–2031 (USD MILLION) 143.
TABLE 117 MIDDLE EAST: FLOW-THROUGH MEMBRANE CHROMATOGRAPHY MARKET, BY REGION,.
2023–2031 (USD MILLION) 143.
TABLE 118 GCC COUNTRIES: FLOW-THROUGH MEMBRANE CHROMATOGRAPHY MARKET, BY COUNTRY,.
2023–2031 (USD MILLION) 144.
TABLE 119 BIND-ELUTE MEMBRANE CHROMATOGRAPHY MARKET, BY REGION, 2023–2031 (USD MILLION) 144.
TABLE 120 NORTH AMERICA: BIND-ELUTE MEMBRANE CHROMATOGRAPHY MARKET, BY COUNTRY,.
2023–2031 (USD MILLION) 145.
TABLE 121 EUROPE: BIND-ELUTE MEMBRANE CHROMATOGRAPHY MARKET, BY COUNTRY, 2023–2031 (USD MILLION) 145.
TABLE 122 ASIA PACIFIC: BIND-ELUTE MEMBRANE CHROMATOGRAPHY MARKET, BY COUNTRY,.
2023–2031 (USD MILLION) 145.
TABLE 123 LATIN AMERICA: BIND-ELUTE MEMBRANE CHROMATOGRAPHY MARKET, BY COUNTRY,.
2023–2031 (USD MILLION) 146.
TABLE 124 MIDDLE EAST: BIND-ELUTE MEMBRANE CHROMATOGRAPHY MARKET, BY REGION,.
2023–2031 (USD MILLION) 146.
TABLE 125 GCC COUNTRIES: BIND-ELUTE MEMBRANE CHROMATOGRAPHY MARKET, BY COUNTRY,.
2023–2031 (USD MILLION) 146.
TABLE 126 MEMBRANE CHROMATOGRAPHY MARKET, BY MEMBRANE MATERIAL, 2023–2031 (USD MILLION) 148.
TABLE 127 EXAMPLES OF POLYETHERSULFONE (PES) MEMBRANE CHROMATOGRAPHY PRODUCTS 149.
TABLE 128 MEMBRANE CHROMATOGRAPHY MARKET FOR POLYETHERSULFONE, BY REGION, 2023–2031 (USD MILLION) 149.
TABLE 129 NORTH AMERICA: MEMBRANE CHROMATOGRAPHY MARKET FOR POLYETHERSULFONE, BY COUNTRY,.
2023–2031 (USD MILLION) 150.
TABLE 130 EUROPE: MEMBRANE CHROMATOGRAPHY MARKET FOR POLYETHERSULFONE, BY COUNTRY,.
2023–2031 (USD MILLION) 150.
TABLE 131 ASIA PACIFIC: MEMBRANE CHROMATOGRAPHY MARKET FOR POLYETHERSULFONE, BY COUNTRY,.
2023–2031 (USD MILLION) 150.
TABLE 132 LATIN AMERICA: MEMBRANE CHROMATOGRAPHY MARKET FOR POLYETHERSULFONE, BY COUNTRY,.
2023–2031 (USD MILLION) 151.
TABLE 133 MIDDLE EAST: MEMBRANE CHROMATOGRAPHY MARKET FOR POLYETHERSULFONE, BY REGION,.
2023–2031 (USD MILLION) 151.
TABLE 134 GCC COUNTRIES: MEMBRANE CHROMATOGRAPHY MARKET FOR POLYETHERSULFONE, BY COUNTRY,.
2023–2031 (USD MILLION) 151.
TABLE 135 EXAMPLES OF CELLULOSE MEMBRANE CHROMATOGRAPHY PRODUCTS 152.
TABLE 136 MEMBRANE CHROMATOGRAPHY MARKET FOR CELLULOSE, BY REGION, 2023–2031 (USD MILLION) 153.
TABLE 137 NORTH AMERICA: MEMBRANE CHROMATOGRAPHY MARKET FOR CELLULOSE, BY COUNTRY,.
2023–2031 (USD MILLION) 153.
TABLE 138 EUROPE: MEMBRANE CHROMATOGRAPHY MARKET FOR CELLULOSE, BY COUNTRY,.
2023–2031 (USD MILLION) 153.
TABLE 139 ASIA PACIFIC: MEMBRANE CHROMATOGRAPHY MARKET FOR CELLULOSE, BY COUNTRY,.
2023–2031 (USD MILLION) 154.
TABLE 140 LATIN AMERICA: MEMBRANE CHROMATOGRAPHY MARKET FOR CELLULOSE, BY COUNTRY,.
2023–2031 (USD MILLION) 154.
TABLE 141 MIDDLE EAST: MEMBRANE CHROMATOGRAPHY MARKET FOR CELLULOSE, BY REGION,.
2023–2031 (USD MILLION) 154.
TABLE 142 GCC COUNTRIES: MEMBRANE CHROMATOGRAPHY MARKET FOR CELLULOSE, BY COUNTRY,.
2023–2031 (USD MILLION) 155.
TABLE 143 EXAMPLES OF HYDROGEL MEMBRANE CHROMATOGRAPHY PRODUCTS 155.
TABLE 144 MEMBRANE CHROMATOGRAPHY MARKET FOR HYDROGEL, BY REGION, 2023–2031 (USD MILLION) 156.
TABLE 145 NORTH AMERICA: MEMBRANE CHROMATOGRAPHY MARKET FOR HYDROGEL, BY COUNTRY,.
2023–2031 (USD MILLION) 156.
TABLE 146 EUROPE: MEMBRANE CHROMATOGRAPHY MARKET FOR HYDROGEL, BY COUNTRY,.
2023–2031 (USD MILLION) 156.
TABLE 147 ASIA PACIFIC: MEMBRANE CHROMATOGRAPHY MARKET FOR HYDROGEL, BY COUNTRY,.
2023–2031 (USD MILLION) 157.
TABLE 148 LATIN AMERICA: MEMBRANE CHROMATOGRAPHY MARKET FOR HYDROGEL, BY COUNTRY,.
2023–2031 (USD MILLION) 157.
TABLE 149 MIDDLE EAST: MEMBRANE CHROMATOGRAPHY MARKET FOR HYDROGEL, BY REGION,.
2023–2031 (USD MILLION) 157.
TABLE 150 GCC COUNTRIES: MEMBRANE CHROMATOGRAPHY MARKET FOR HYDROGEL, BY COUNTRY,.
2023–2031 (USD MILLION) 158.
TABLE 151 MEMBRANE CHROMATOGRAPHY MARKET FOR OTHER MEMBRANE MATERIALS, BY REGION,.
2023–2031 (USD MILLION) 159.
TABLE 152 NORTH AMERICA: MEMBRANE CHROMATOGRAPHY MARKET FOR OTHER MEMBRANE MATERIALS, BY COUNTRY, 2023–2031 (USD MILLION) 159.
TABLE 153 EUROPE: MEMBRANE CHROMATOGRAPHY MARKET FOR OTHER MEMBRANE MATERIALS, BY COUNTRY,.
2023–2031 (USD MILLION) 159.
TABLE 154 ASIA PACIFIC: MEMBRANE CHROMATOGRAPHY MARKET FOR OTHER MEMBRANE MATERIALS, BY COUNTRY, 2023–2031 (USD MILLION) 160.
TABLE 155 LATIN AMERICA: MEMBRANE CHROMATOGRAPHY MARKET FOR OTHER MEMBRANE MATERIALS, BY COUNTRY, 2023–2031 (USD MILLION) 160.
TABLE 156 MIDDLE EAST: MEMBRANE CHROMATOGRAPHY MARKET FOR OTHER MEMBRANE MATERIALS, BY REGION,.
2023–2031 (USD MILLION) 160.
TABLE 157 GCC COUNTRIES: MEMBRANE CHROMATOGRAPHY MARKET FOR OTHER MEMBRANE MATERIALS, BY COUNTRY, 2023–2031 (USD MILLION) 161.
TABLE 158 MEMBRANE CHROMATOGRAPHY MARKET, BY END USER, 2023–2031 (USD MILLION) 163.
TABLE 159 MEMBRANE CHROMATOGRAPHY MARKET FOR PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES,.
BY REGION, 2023–2031 (USD MILLION) 164.
TABLE 160 NORTH AMERICA: MEMBRANE CHROMATOGRAPHY MARKET FOR PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES, BY COUNTRY, 2023–2031 (USD MILLION) 164.
TABLE 161 EUROPE: MEMBRANE CHROMATOGRAPHY MARKET FOR PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES, BY COUNTRY, 2023–2031 (USD MILLION) 164.
TABLE 162 ASIA PACIFIC: MEMBRANE CHROMATOGRAPHY MARKET FOR PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES, BY COUNTRY, 2023–2031 (USD MILLION) 165.
TABLE 163 LATIN AMERICA: MEMBRANE CHROMATOGRAPHY MARKET FOR PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES, BY COUNTRY, 2023–2031 (USD MILLION) 165.
TABLE 164 MIDDLE EAST: MEMBRANE CHROMATOGRAPHY MARKET FOR PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES, BY REGION, 2023–2031 (USD MILLION) 165.
TABLE 165 GCC COUNTRIES: MEMBRANE CHROMATOGRAPHY MARKET FOR PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES, BY COUNTRY, 2023–2031 (USD MILLION) 166.
TABLE 166 MEMBRANE CHROMATOGRAPHY MARKET FOR CROS & CDMOS, BY REGION, 2023–2031 (USD MILLION) 167.
TABLE 167 NORTH AMERICA: MEMBRANE CHROMATOGRAPHY MARKET FOR CROS & CDMOS, BY COUNTRY,.
2023–2031 (USD MILLION) 167.
TABLE 168 EUROPE: MEMBRANE CHROMATOGRAPHY MARKET FOR CROS & CDMOS, BY COUNTRY,.
2023–2031 (USD MILLION) 167.
TABLE 169 ASIA PACIFIC: MEMBRANE CHROMATOGRAPHY MARKET FOR CROS & CDMOS, BY COUNTRY,.
2023–2031 (USD MILLION) 168.
TABLE 170 LATIN AMERICA: MEMBRANE CHROMATOGRAPHY MARKET FOR CROS & CDMOS, BY COUNTRY,.
2023–2031 (USD MILLION) 168.
TABLE 171 MIDDLE EAST: MEMBRANE CHROMATOGRAPHY MARKET FOR CROS & CDMOS, BY REGION,.
2023–2031 (USD MILLION) 168.
TABLE 172 GCC COUNTRIES: MEMBRANE CHROMATOGRAPHY MARKET FOR CROS & CDMOS, BY COUNTRY,.
2023–2031 (USD MILLION) 169.
TABLE 173 MEMBRANE CHROMATOGRAPHY MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION,.
2023–2031 (USD MILLION) 170.
TABLE 174 NORTH AMERICA: MEMBRANE CHROMATOGRAPHY MARKET FOR ACADEMIC & RESEARCH INSTITUTES,.
BY COUNTRY, 2023–2031 (USD MILLION) 170.
TABLE 175 EUROPE: MEMBRANE CHROMATOGRAPHY MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2023–2031 (USD MILLION) 170.
TABLE 176 ASIA PACIFIC: MEMBRANE CHROMATOGRAPHY MARKET FOR ACADEMIC & RESEARCH INSTITUTES,.
BY COUNTRY, 2023–2031 (USD MILLION) 171.
TABLE 177 LATIN AMERICA: MEMBRANE CHROMATOGRAPHY MARKET FOR ACADEMIC & RESEARCH INSTITUTES,.
BY COUNTRY, 2023–2031 (USD MILLION) 171.
TABLE 178 MIDDLE EAST: MEMBRANE CHROMATOGRAPHY MARKET FOR ACADEMIC & RESEARCH INSTITUTES,.
BY REGION, 2023–2031 (USD MILLION) 171.
TABLE 179 GCC COUNTRIES: MEMBRANE CHROMATOGRAPHY MARKET FOR ACADEMIC & RESEARCH INSTITUTES,.
BY COUNTRY, 2023–2031 (USD MILLION) 172.
TABLE 180 MEMBRANE CHROMATOGRAPHY MARKET, BY REGION, 2023–2031 (USD MILLION) 174.
TABLE 181 US: THERAPEUTIC MONOCLONAL ANTIBODIES APPROVED, 2023–2025 175.
TABLE 182 NORTH AMERICA: MEMBRANE CHROMATOGRAPHY MARKET, BY COUNTRY, 2023–2031 (USD MILLION) 176.
TABLE 183 NORTH AMERICA: MEMBRANE CHROMATOGRAPHY MARKET, BY PRODUCT, 2023–2031 (USD MILLION) 176.
TABLE 184 NORTH AMERICA: MEMBRANE CHROMATOGRAPHY MARKET, BY TECHNIQUE, 2023–2031 (USD MILLION) 176.
TABLE 185 NORTH AMERICA: ION EXCHANGE MEMBRANE CHROMATOGRAPHY MARKET, BY TYPE,.
2023–2031 (USD MILLION) 177.
TABLE 186 NORTH AMERICA: MEMBRANE CHROMATOGRAPHY MARKET, BY OPERATION MODE,.
2023–2031 (USD MILLION) 177.
TABLE 187 NORTH AMERICA: MEMBRANE CHROMATOGRAPHY MARKET, BY MEMBRANE MATERIAL,.
2023–2031 (USD MILLION) 177.
TABLE 188 NORTH AMERICA: MEMBRANE CHROMATOGRAPHY MARKET, BY END USER, 2023–2031 (USD MILLION) 178.
TABLE 189 US: MEMBRANE CHROMATOGRAPHY MARKET, BY PRODUCT, 2023–2031 (USD MILLION) 179.
TABLE 190 US: MEMBRANE CHROMATOGRAPHY MARKET, BY TECHNIQUE, 2023–2031 (USD MILLION) 180.
TABLE 191 US: ION EXCHANGE MEMBRANE CHROMATOGRAPHY MARKET, BY TYPE, 2023–2031 (USD MILLION) 180.
TABLE 192 US: MEMBRANE CHROMATOGRAPHY MARKET, BY OPERATION MODE, 2023–2031 (USD MILLION) 180.
TABLE 193 US: MEMBRANE CHROMATOGRAPHY MARKET, BY MEMBRANE MATERIAL, 2023–2031 (USD MILLION) 181.
TABLE 194 US: MEMBRANE CHROMATOGRAPHY MARKET, BY END USER, 2023–2031 (USD MILLION) 181.
TABLE 195 CANADA: MEMBRANE CHROMATOGRAPHY MARKET, BY PRODUCT, 2023–2031 (USD MILLION) 182.
TABLE 196 CANADA: MEMBRANE CHROMATOGRAPHY MARKET, BY TECHNIQUE, 2023–2031 (USD MILLION) 182.
TABLE 197 CANADA: ION EXCHANGE MEMBRANE CHROMATOGRAPHY MARKET, BY TYPE, 2023–2031 (USD MILLION) 183.
TABLE 198 CANADA: MEMBRANE CHROMATOGRAPHY MARKET, BY OPERATION MODE, 2023–2031 (USD MILLION) 183.
TABLE 199 CANADA: MEMBRANE CHROMATOGRAPHY MARKET, BY MEMBRANE MATERIAL, 2023–2031 (USD MILLION) 183.
TABLE 200 CANADA: MEMBRANE CHROMATOGRAPHY MARKET, BY END USER, 2023–2031 (USD MILLION) 184.
TABLE 201 EUROPE: LIST OF APPROVED MONOCLONAL ANTIBODY TREATMENTS 184.
TABLE 202 EUROPE: MEMBRANE CHROMATOGRAPHY MARKET, BY COUNTRY, 2023–2031 (USD MILLION) 185.
TABLE 203 EUROPE: MEMBRANE CHROMATOGRAPHY MARKET, BY PRODUCT, 2023–2031 (USD MILLION) 185.
TABLE 204 EUROPE: MEMBRANE CHROMATOGRAPHY MARKET, BY TECHNIQUE, 2023–2031 (USD MILLION) 186.
TABLE 205 EUROPE: ION EXCHANGE MEMBRANE CHROMATOGRAPHY MARKET, BY TYPE, 2023–2031 (USD MILLION) 186.
TABLE 206 EUROPE: MEMBRANE CHROMATOGRAPHY MARKET, BY OPERATION MODE, 2023–2031 (USD MILLION) 186.
TABLE 207 EUROPE: MEMBRANE CHROMATOGRAPHY MARKET, BY MEMBRANE MATERIAL, 2023–2031 (USD MILLION) 187.
TABLE 208 EUROPE: MEMBRANE CHROMATOGRAPHY MARKET, BY END USER, 2023–2031 (USD MILLION) 187.
TABLE 209 GERMANY: MEMBRANE CHROMATOGRAPHY MARKET, BY PRODUCT, 2023–2031 (USD MILLION) 188.
TABLE 210 GERMANY: MEMBRANE CHROMATOGRAPHY MARKET, BY TECHNIQUE, 2023–2031 (USD MILLION) 188.
TABLE 211 GERMANY: ION EXCHANGE MEMBRANE CHROMATOGRAPHY MARKET, BY TYPE, 2023–2031 (USD MILLION) 189.
TABLE 212 GERMANY: MEMBRANE CHROMATOGRAPHY MARKET, BY OPERATION MODE, 2023–2031 (USD MILLION) 189.
TABLE 213 GERMANY: MEMBRANE CHROMATOGRAPHY MARKET, BY MEMBRANE MATERIAL, 2023–2031 (USD MILLION) 189.
TABLE 214 GERMANY: MEMBRANE CHROMATOGRAPHY MARKET, BY END USER, 2023–2031 (USD MILLION) 190.
TABLE 215 UK: MEMBRANE CHROMATOGRAPHY MARKET, BY PRODUCT, 2023–2031 (USD MILLION) 190.
TABLE 216 UK: MEMBRANE CHROMATOGRAPHY MARKET, BY TECHNIQUE, 2023–2031 (USD MILLION) 191.
TABLE 217 UK: ION EXCHANGE MEMBRANE CHROMATOGRAPHY MARKET, BY TYPE, 2023–2031 (USD MILLION) 191.
TABLE 218 UK: MEMBRANE CHROMATOGRAPHY MARKET, BY OPERATION MODE, 2023–2031 (USD MILLION) 191.
TABLE 219 UK: MEMBRANE CHROMATOGRAPHY MARKET, BY MEMBRANE MATERIAL, 2023–2031 (USD MILLION) 192.
TABLE 220 UK: MEMBRANE CHROMATOGRAPHY MARKET, BY END USER, 2023–2031 (USD MILLION) 192.
TABLE 221 FRANCE: MEMBRANE CHROMATOGRAPHY MARKET, BY PRODUCT, 2023–2031 (USD MILLION) 193.
TABLE 222 FRANCE: MEMBRANE CHROMATOGRAPHY MARKET, BY TECHNIQUE, 2023–2031 (USD MILLION) 193.
TABLE 223 FRANCE: ION EXCHANGE MEMBRANE CHROMATOGRAPHY MARKET, BY TYPE, 2023–2031 (USD MILLION) 193.
TABLE 224 FRANCE: MEMBRANE CHROMATOGRAPHY MARKET, BY OPERATION MODE, 2023–2031 (USD MILLION) 194.
TABLE 225 FRANCE: MEMBRANE CHROMATOGRAPHY MARKET, BY MEMBRANE MATERIAL, 2023–2031 (USD MILLION) 194.
TABLE 226 FRANCE: MEMBRANE CHROMATOGRAPHY MARKET, BY END USER, 2023–2031 (USD MILLION) 194.
TABLE 227 ITALY: MEMBRANE CHROMATOGRAPHY MARKET, BY PRODUCT, 2023–2031 (USD MILLION) 195.
TABLE 228 ITALY: MEMBRANE CHROMATOGRAPHY MARKET, BY TECHNIQUE, 2023–2031 (USD MILLION) 195.
TABLE 229 ITALY: ION EXCHANGE MEMBRANE CHROMATOGRAPHY MARKET, BY TYPE, 2023–2031 (USD MILLION) 196.
TABLE 230 ITALY: MEMBRANE CHROMATOGRAPHY MARKET, BY OPERATION MODE, 2023–2031 (USD MILLION) 196.
TABLE 231 ITALY: MEMBRANE CHROMATOGRAPHY MARKET, BY MEMBRANE MATERIAL, 2023–2031 (USD MILLION) 196.
TABLE 232 ITALY: MEMBRANE CHROMATOGRAPHY MARKET, BY END USER, 2023–2031 (USD MILLION) 197.
TABLE 233 SPAIN: MEMBRANE CHROMATOGRAPHY MARKET, BY PRODUCT, 2023–2031 (USD MILLION) 197.
TABLE 234 SPAIN: MEMBRANE CHROMATOGRAPHY MARKET, BY TECHNIQUE, 2023–2031 (USD MILLION) 198.
TABLE 235 SPAIN: ION EXCHANGE MEMBRANE CHROMATOGRAPHY MARKET, BY TYPE, 2023–2031 (USD MILLION) 198.
TABLE 236 SPAIN: MEMBRANE CHROMATOGRAPHY MARKET, BY OPERATION MODE, 2023–2031 (USD MILLION) 198.
TABLE 237 SPAIN: MEMBRANE CHROMATOGRAPHY MARKET, BY MEMBRANE MATERIAL, 2023–2031 (USD MILLION) 199.
TABLE 238 SPAIN: MEMBRANE CHROMATOGRAPHY MARKET, BY END USER, 2023–2031 (USD MILLION) 199.
TABLE 239 REST OF EUROPE: MEMBRANE CHROMATOGRAPHY MARKET, BY PRODUCT, 2023–2031 (USD MILLION) 200.
TABLE 240 REST OF EUROPE: MEMBRANE CHROMATOGRAPHY MARKET, BY TECHNIQUE, 2023–2031 (USD MILLION) 200.
TABLE 241 REST OF EUROPE: ION EXCHANGE MEMBRANE CHROMATOGRAPHY MARKET, BY TYPE,.
2023–2031 (USD MILLION) 200.
TABLE 242 REST OF EUROPE: MEMBRANE CHROMATOGRAPHY MARKET, BY OPERATION MODE,.
2023–2031 (USD MILLION) 201.
TABLE 243 REST OF EUROPE: MEMBRANE CHROMATOGRAPHY MARKET, BY MEMBRANE MATERIAL,.
2023–2031 (USD MILLION) 201.
TABLE 244 REST OF EUROPE: MEMBRANE CHROMATOGRAPHY MARKET, BY END USER, 2023–2031 (USD MILLION) 201.
TABLE 245 ASIA PACIFIC: MEMBRANE CHROMATOGRAPHY MARKET, BY COUNTRY, 2023–2031 (USD MILLION) 203.
TABLE 246 ASIA PACIFIC: MEMBRANE CHROMATOGRAPHY MARKET, BY PRODUCT, 2023–2031 (USD MILLION) 203.
TABLE 247 ASIA PACIFIC: MEMBRANE CHROMATOGRAPHY MARKET, BY TECHNIQUE, 2023–2031 (USD MILLION) 204.
TABLE 248 ASIA PACIFIC: ION EXCHANGE MEMBRANE CHROMATOGRAPHY MARKET, BY TYPE, 2023–2031 (USD MILLION) 204.
TABLE 249 ASIA PACIFIC: MEMBRANE CHROMATOGRAPHY MARKET, BY OPERATION MODE, 2023–2031 (USD MILLION) 204.
TABLE 250 ASIA PACIFIC: MEMBRANE CHROMATOGRAPHY MARKET, BY MEMBRANE MATERIAL,.
2023–2031 (USD MILLION) 205.
TABLE 251 ASIA PACIFIC: MEMBRANE CHROMATOGRAPHY MARKET, BY END USER, 2023–2031 (USD MILLION) 205.
TABLE 252 CHINA: MEMBRANE CHROMATOGRAPHY MARKET, BY PRODUCT, 2023–2031 (USD MILLION) 206.
TABLE 253 CHINA: MEMBRANE CHROMATOGRAPHY MARKET, BY TECHNIQUE, 2023–2031 (USD MILLION) 206.
TABLE 254 CHINA: ION EXCHANGE MEMBRANE CHROMATOGRAPHY MARKET, BY TYPE, 2023–2031 (USD MILLION) 206.
TABLE 255 CHINA: MEMBRANE CHROMATOGRAPHY MARKET, BY OPERATION MODE, 2023–2031 (USD MILLION) 207.
TABLE 256 CHINA: MEMBRANE CHROMATOGRAPHY MARKET, BY MEMBRANE MATERIAL, 2023–2031 (USD MILLION) 207.
TABLE 257 CHINA: MEMBRANE CHROMATOGRAPHY MARKET, BY END USER, 2023–2031 (USD MILLION) 207.
TABLE 258 JAPAN: MEMBRANE CHROMATOGRAPHY MARKET, BY PRODUCT, 2023–2031 (USD MILLION) 208.
TABLE 259 JAPAN: MEMBRANE CHROMATOGRAPHY MARKET, BY TECHNIQUE, 2023–2031 (USD MILLION) 208.
TABLE 260 JAPAN: ION EXCHANGE MEMBRANE CHROMATOGRAPHY MARKET, BY TYPE, 2023–2031 (USD MILLION) 209.
TABLE 261 JAPAN: MEMBRANE CHROMATOGRAPHY MARKET, BY OPERATION MODE, 2023–2031 (USD MILLION) 209.
TABLE 262 JAPAN: MEMBRANE CHROMATOGRAPHY MARKET, BY MEMBRANE MATERIAL, 2023–2031 (USD MILLION) 210.
TABLE 263 JAPAN: MEMBRANE CHROMATOGRAPHY MARKET, BY END USER, 2023–2031 (USD MILLION) 210.
TABLE 264 INDIA: MEMBRANE CHROMATOGRAPHY MARKET, BY PRODUCT, 2023–2031 (USD MILLION) 211.
TABLE 265 INDIA: MEMBRANE CHROMATOGRAPHY MARKET, BY TECHNIQUE, 2023–2031 (USD MILLION) 211.
TABLE 266 INDIA: ION EXCHANGE MEMBRANE CHROMATOGRAPHY MARKET, BY TYPE, 2023–2031 (USD MILLION) 211.
TABLE 267 INDIA: MEMBRANE CHROMATOGRAPHY MARKET, BY OPERATION MODE, 2023–2031 (USD MILLION) 212.
TABLE 268 INDIA: MEMBRANE CHROMATOGRAPHY MARKET, BY MEMBRANE MATERIAL, 2023–2031 (USD MILLION) 212.
TABLE 269 INDIA: MEMBRANE CHROMATOGRAPHY MARKET, BY END USER, 2023–2031 (USD MILLION) 212.
TABLE 270 SOUTH KOREA: MEMBRANE CHROMATOGRAPHY MARKET, BY PRODUCT, 2023–2031 (USD MILLION) 213.
TABLE 271 SOUTH KOREA: MEMBRANE CHROMATOGRAPHY MARKET, BY TECHNIQUE, 2023–2031 (USD MILLION) 213.
TABLE 272 SOUTH KOREA: ION EXCHANGE MEMBRANE CHROMATOGRAPHY MARKET, BY TYPE,.
2023–2031 (USD MILLION) 214.
TABLE 273 SOUTH KOREA: MEMBRANE CHROMATOGRAPHY MARKET, BY OPERATION MODE, 2023–2031 (USD MILLION) 214.
TABLE 274 SOUTH KOREA: MEMBRANE CHROMATOGRAPHY MARKET, BY MEMBRANE MATERIAL,.
2023–2031 (USD MILLION) 214.
TABLE 275 SOUTH KOREA: MEMBRANE CHROMATOGRAPHY MARKET, BY END USER, 2023–2031 (USD MILLION) 215.
TABLE 276 AUSTRALIA: MEMBRANE CHROMATOGRAPHY MARKET, BY PRODUCT, 2023–2031 (USD MILLION) 215.
TABLE 277 AUSTRALIA: MEMBRANE CHROMATOGRAPHY MARKET, BY TECHNIQUE, 2023–2031 (USD MILLION) 216.
TABLE 278 AUSTRALIA: ION EXCHANGE MEMBRANE CHROMATOGRAPHY MARKET, BY TYPE, 2023–2031 (USD MILLION) 216.
TABLE 279 AUSTRALIA: MEMBRANE CHROMATOGRAPHY MARKET, BY OPERATION MODE, 2023–2031 (USD MILLION) 216.
TABLE 280 AUSTRALIA: MEMBRANE CHROMATOGRAPHY MARKET, BY MEMBRANE MATERIAL,.
2023–2031 (USD MILLION) 217.
TABLE 281 AUSTRALIA: MEMBRANE CHROMATOGRAPHY MARKET, BY END USER, 2023–2031 (USD MILLION) 217.
TABLE 282 REST OF ASIA PACIFIC: MEMBRANE CHROMATOGRAPHY MARKET, BY PRODUCT, 2023–2031 (USD MILLION) 218.
TABLE 283 REST OF ASIA PACIFIC: MEMBRANE CHROMATOGRAPHY MARKET, BY TECHNIQUE, 2023–2031 (USD MILLION) 218.

 

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります

本レポートと同分野(バイオ薬物)の最新刊レポート

MarketsandMarkets社の Biotechnology分野 での最新刊レポート


よくあるご質問


MarketsandMarkets社はどのような調査会社ですか?


マーケッツアンドマーケッツ(MarketsandMarkets)は通信、半導体、医療機器、エネルギーなど、幅広い市場に関する調査レポートを出版しています。また広範な市場を対象としたカスタム調査も行って... もっと見る


調査レポートの納品までの日数はどの程度ですか?


在庫のあるものは速納となりますが、平均的には 3-4日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。


注文の手続きはどのようになっていますか?


1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。


お支払方法の方法はどのようになっていますか?


納品と同時にデータリソース社よりお客様へ請求書(必要に応じて納品書も)を発送いたします。
お客様よりデータリソース社へ(通常は円払い)の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。


データリソース社はどのような会社ですか?


当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。


詳細検索

このレポートへのお問合せ

03-3582-2531

電話お問合せもお気軽に

 

 

2026/11/19 10:27

160.48 円

176.53 円

213.76 円

ページTOPに戻る